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Met, either bound in proteins or in its free form is easily oxidized to Met(O) by reactive oxygen 
species. Met(O)-containing proteins accumulate during ageing and may play a role in degenerative 
diseases. Because of the chirality of the sulfoxide moiety, Met(O) exists as a pair of diastereomers 
Met-S-(O) and Met-R-(O). For the reduction of the diastereomers, stereospecific Msr enzymes exist. 
MsrA reduces free and protein-bound Met-S-(O), while MsrB reduces protein-bound Met-R-(O) with 
little affinity for free Met-R-(O). The latter is reduced by fRMsr. The aim of the present study was 
the development of stereospecific CE assays for Msr enzymes in order to study the stereospecificity 
of the enzymes. The substrates included Met(O), Met(O) derivatives as well as Met(O)-containing 
peptides. Upon establishment of the separation conditions, the methods were validated and 
subsequently applied for assaying recombinant human and fungal MsrA and MsrB enzymes.  
An off-line assay was developed using free Met(O) as substrate. The separation of the Met(O) 
diastereomers, the product Met as well as β-alanine as internal standard was achieved upon 
derivatization of the analytes with dabsyl chloride by a MEKC method in a SMIL-coated capillary. 
The capillary coating consisted of a first layer of polybrene and a second layer of dextran sulfate 
providing a stable strong cathodic EOF and, consequently, highly repeatable analyte migration times. 
The assay was subsequently applied to screen the stereospecific activity of recombinant hMsrA and 
fungal fRMsr enzymes as well as to determine the Michaelis-Menten kinetics. An advantage of the 
present assay over existing assays is the fact that free Met(O) can be used as the natural substrate. In 
the assay, DTT was used as reducing agent for Msr recycling instead of using the coupled reaction 
involving Trx and Trx reductase so that no additional enzymes were required. 
An in-capillary EMMA assay was established using Fmoc-Met(O) as substrate. The separation of 
diastereomers of Fmoc-Met(O), the product Fmoc-Met and the internal standard Fmoc--alanine 
was also achieved in a SMIl-coated capillary by a MEKC method. The partial filling mode was 
applied because the BGE contained SDS, which would lead to the denaturation of the enzyme. An 
injection sequence of incubation buffer-enzyme-substrate-enzyme-incubation buffer was selected. 
The assay was optimized with regard to the mixing time with a mixing voltage and subsequently 
applied for the analysis of stereospecificity of human MsrA and MsrB2. The Michaelis-Menten 
constant, Km, and the maximum velocity, Vmax, were determined. Essentially identical data were 
determined by the EMMA mode compared to off-line incubations. Compared to the off-line assay, 
the EMMA assay was fully automated and required smaller amounts of enzyme and substrates, thus, 




For the development of an assay using peptide substrates, the C-terminally dinitrophenyl-labeled, N-
acetylated pentapeptide KIFM(O)K was chosen. The separation of the KIFM(O)K diastereomers and 
the reduced peptide KIFMK was achieved in a BGE containing sulfated β-CD and 15-crown-5 as 
buffer additives. The system was optimized using experimental design with regard to the buffer pH, 
ionic strength, sulfated β-CD and 15-crown-5, as well as capillary temperature and separation 
voltage. A fractional factorial response IV design was employed for the identification of the 
significant experimental factors and a five-level circumscribed central composite design for the final 
method optimization. The assay was successfully applied for the characterization of the 
stereospecificity of recombinant human MsrA and MsrB2 including the determination of the 
Michaelis-Menten kinetic data. Using this peptide substrate, lower Km values but significantly higher 
kcat constants were observed as compared to literature data reported for the substrates dabsyl-Met(O) 
and Fmoc-Met(O). Thus, the present pentapeptide-based assay may represent Msr activities towards 
protein-bound Met(O) in a better way as compared to simple amino acid derivative-based assays. 
In order to better understand previous data that MsrA enzyme had a preference for peptide substrates 
with positively charged residues flanking Met(O), a group of peptide substrates was employed in 
combination with wild-type fungal MsrA and three mutants. The present data were in general 
agreement with the previous non-stereospecific assay except that the DE mutant (Glu99, Glu134) 
was not found to be more active than the wild-type enzyme for the reduction of KDM(O)DK. 
Interestingly, a reversed substrate preference was observed between the mutants DN (Glu99, 
Asn134) and EQ (Gln99, Asp134) reducing KDM(O)NK and KNM(O)DK. The asymmetric 
negative charges in the active center may explain this behavior. Molecular modelling was performed 
to rationalize the specificity and indicated that the conserved residue Glu99 in the active site of MsrA 
was buried in the Met-S-(O) binding groove, which might contribute to the right placing of Met-S-
(O) and, consequently, to the catalytic activity of MsrA. 
Finally, the dual selector system composed of a CD and a crown ether for the separation of the 
Met(O) peptide diastereomers was studied systematically using a series of N-acetylated Met(O) 
pentapeptides with a Dnp label at the C-terminus. Depending on the amino acid sequence and the 
applied CD, the addition of crown ethers, especially of the Krpytofix® diaza-crown ethers, resulted in 
a significant improvement of the resolution of the diastereomers of peptides containing basic amino 
acids. Charged CD derivatives such as carboxymethyl-β-CD and sulfated β-CD were superior 
compared to native β-CD. In contrast, the diastereomer separation of Met(O) peptides containing 





Met, entweder als Bestandteil von Proteinen oder frei vorliegend, kann durch reaktive Sauerstoffspezies zu 
Met(O) oxidiert werden. Met(O)-enthaltende Proteine akkumulieren während des Alterns im Körper und 
können an der Entstehung degenerativer Erkrankungen beteiligt sein. Aufgrund der Chiralität der Sulfoxid-
Gruppe existiert Met(O) als das Diastereomerenpaar Met-S-(O) und Met-R-(O). Für die Reduktion der 
Diastereomere existieren stereospezifische Methioninsulfoxid-Rduktasen (Msr). MsrA reduziert freies sowie 
proteingebundenes Met-S-(O), MrsB-Enzyme bevorzugen proteingebundenes Met-S-(O). Das Enzym fRMsr 
redzuziert freies Met-R-(O).  
Die vorliegende Arbeit beschreibt die Entwicklung stereospezifischer Untersuchungsmethoden für Msr-
Enzyme mittels Kapillarelektrophorese einschließlich off-line und online Assays. Folgende Substrate wurden 
verwendet: Met(O), Met(O)-Derivate und Met(O)-enthaltende Peptide. Nach der Etablierung der 
Trennbedingungen der Met(O)-Diastereomere und Met, erfolgte die Validierung dieser Verfahren. 
Für eionen offline-Assay wurde Met(O) als Substrat eingesetzt. Die Met(O)-Diastereomere, Met 
(Reaktionsprodukt) und β-Alanin (interner Standard) wurden nach der Derivatisierung mit Dabsylchlorid in 
einer SMIL-Kapillare mittels einer MEKC-Methode getrennt. Die Kapillarbeschichtung bestand aus einre 
Hexadimethrine- und einer Dextransulfat-Schicht. Durch diese Beschichtung ergab sich ein starker und 
stabiler kathodischer EOF mit gut reproduzierbaren Migrationszeiten. Die Methode wurde zum Screening der 
stereospezifischen Aktivität von hMsrA und aus Pilzen stammender fRMsr sowie zur Bestimmung der 
Michaelis-Menten Enzymkinetik eingesetzt. Ein Vorteil der Methode ist, dass freies Met(O) unmittelbar als 
Substrat angewendet werden konnte. DTT diente zum Recycling der Msr , so dass verglichen mit anderen 
Methoden, bei denen Trx- und Trx-Reduktase eingesetzt wurden, keine weiteren Enzyme notwendig waren.  
Für den online-Assay kam Fmoc-Met(O) als Substraz zum Einsatz. Die Trennung der Diastereomere von 
Fmoc-Met(O), der reduzierten Spezies Fmoc-Met und des internen Standards erfolgte ebenfalls in einer 
Kapillare mit SMIL-Beschichtung unter Verwendung der MEKC. Die Injektionssequenz wurde wie folgt 
gewählt: Inkubationspuffer, Enzym, Substrat, Enzym Inkubationspuffer. Die Methode wurde im Hinblick auf 
Dauer und Höhe der angelegten Spannung, die zur Mischung der injizierten Plugs notwendig war, optimiert. 
Die Methode wurde zur Analyse der stereospezifischen Reaktionen der humanen Enzyme MsrA und MsrB2 
verwendet. Weiterhin wurden die Michaelis-Menten-Konstante, Km, und die maximale 
Reaktionsgeschwindigkeit, Vmax, bestimmt. Die Daten waren vergleichbar mit Literaturdaten.Verglichen mit 
einem offline-Assay, konnte der EMMA-Assay in kürzerer Zeit mit geringerem Aufwand durchgeführt 
werden. Aufgrund der Automatisierung wurden geringere Proben- und Enzymmengen verbraucht, was die 




Als Peptid-Substrat wurde ein C-terminal mit Dinitrophenyl-Gruppe markiertes, N-acetyliertes Pentapeptid, 
KIFM(O)K, verwendet. Für die Trennung der KIFM(O)K-Diastereomere und des reduzierten Peptids KIFMK 
wurde folgende Faktoren optimiert: pH-Wert des Puffers, Pufferkonzentration, Konzentration des sulfatierten 
β-Cyclodextrins, Konzentration des Kronenethers 15-Krone-5, Kapillartemperatur und Spannung. Ein 
Fractional-Factorial-Response-IV-Design kam zur Bestimmung der signifikanten Faktoren zum Einsatz. Für 
die Methodenoptimierung wurde ein fünf Ebenen umschreibendes Central-Composite-Design gewählt. Das 
CE-Verfahren wurde zur Bestimmung der Stereospezifität humaner MsrA und MsrB2 einschließlich der 
Bestimmung der Michaelis-Menten-Kinetik verwendet. Verglichen mit Literaturwerten für dabsyl-Met(O) 
und Fmoc-Met(O), wurden niedrigere Km-Werte, aber  signifikant höhere kcat-Konstanten ermittelt. Folglich 
bildet der vorliegende pentapeptidbasierte Assay die Msr-Enzymaktivitäten für proteingebundenes Met(O) 
besser ab, als auf Aminosäurederivaten basierende Methoden. 
In vorangegangenen, nicht stereospezifischen Untersuchungen wurde festgestellt, dass MsrA Peptide 
bevorzugt umgesetzt hatte, bei denen Met(O) von positiv geladenen Aminosäureresten flankiert war. Zur 
Verifizierung dieses Sachverhalts wurden Peptide mit von Pilzen stammender Wildtyp-MsrA sowie drei ihrer 
Mutanten untersucht. Die Ergebnisse bestätigten diese Beobachtung. Die DE-Mutante (Glu99, Glu131) zeigte 
allerdings keine stärkere Aktivität gegenüber KDM(O)DK als der Wildtyp. Interessanter Weise wurde eine 
umgekehrte Substratpräferenz zwischen den Mutanten DN (Glu99, Asn134) und EQ (Gln99, Asp134) 
bezüglich der Reduktion von KDM(O)NK und KNM(O)DK festgestellt. Die asymmetrisch verteilte negative 
Ladung im aktiven Zentrum könnte dieses Verhalten erklären. Mit Hilfe von Molecular Modelling 
Untersuchungenkonnte gezeigt werden, dass die konservierte, tief im aktiven Zentrum der Met-S-(O)-
Bindungstasche liegende Aminosäure Glu99, einen Einfluss auf die korrekte Bindung von Met-S-(O) und 
somit auch auf die katalytische Aktivität von MsrA hat. 
Zusaätzlich wurde die Trennung der Diastereomere von N-acetylierten, C-dabsylierten Met(O)-Pentapeptiden 
bezüglich der Selektoren Cyclodextrin und Kronenether im Trennelektrolyt systematisch untersuchtIn 
Abhängigkeit der Aminosäuresequenz und des verwendeten Cyclodextrins führte der Zusatz von 
Kronenethern, insbesondere Kryptofix® (Diaza-Kronenether), zu signifikant verbesserten Auflösungen der 
Diastereomere vom Peptiden, die basische Aminosäuren enthielten. Geladene Cyclodextrine, wie 
Carboxymethyl-β-CD und sulfatiertes β-CD waren nativem β-CD überlegen. Für Met(O)-Peptide, die 
ungeladene Aminosäuren beinhalteten, wurde mit der MEKC unter Verwendung CD-haltiger Puffer ein 




1 Introduction  
1.1 Defining oxidative stress 
Molecular oxygen is essential for the survival of aerobic creature, while the use of oxygen is 
fundamentally dangerous to their existence [1]. Aerobic organisms produce reactive oxygen species 
(ROS) inevitably during oxygen metabolism, which have the ability, either directly or indirectly, to 
damage all biomolecules, including proteins, lipids, DNA, and carbohydrates [2]. ROS, such as 
superoxide anion, hydroxyl radical and hydrogen peroxide, are generated under numerous conditions 
in vivo. The main endogenous source of ROS production is the mitochondrial metabolism, i.e., the 
respiration, when oxygen is reduced to water. Upon incomplete reduction of oxygen, superoxide and 
hydrogen peroxide are generated. The latter can further react with metal ions to form hydroxyl 
radicals [3, 4]. Other sources for ROS are cytochrome P450 metabolism, xanthine oxidase, 
inflammation processes as well as exogenous sources (Fig.1) [2, 5, 6]. Higher eukaryotic aerobic 
organisms cannot survive without oxygen which makes them constantly exposed to various forms of 
ROS. Researches have shown that low levels of ROS are indispensable in many biochemical 
processes in cells, including in signaling pathways [7, 8], gene expression and pathogen elimination 
[9]. However, excessive amounts of ROS are harmful for cells. Given that ROS exist unavoidably 
under aerobic conditions, it is not unexpected that cells and tissues have developed sophisticated 
mechanisms such as antioxidants, enzymes as well as repair systems to counteract oxidative damage 
(Fig. 1).  
Helmut Sies proposed the concept of oxidative stress as “imbalance between oxidants and 
antioxidants in favor of the oxidants, potentially leading to damage” [10], which was later extended 
to a definition that describes a disruption of redox signaling and control [11]. Under normal 
circumstances, the formation of oxidants is counteracted by antioxidants so that there is minimal 
modification of biomolecules. Oxidative stress occurs when the balance of the formation of oxidants 
exceeds the ability of antioxidant system to remove ROS. Thus, biomolecules become subject to 
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Fig. 1: The occurrence of oxidative stress depends on the interaction between the cellular 
antioxidative system and the formation of ROS. When the antioxidative capacity is not 
sufficient in detoxification of ROS products, oxidative stress appears. In this case, the balance 
would be in favor of ROS. Adapted from [2]. 
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When oxidative stress happens in cells, ROS are able to damage cellular components like proteins, 
DNA, carbohydrates as well as polyunsaturated fatty acid [12 - 14]. Thereinto, proteins as most 
abundant constituent in cells are primarily attacked by ROS. Both amino acid residue side chains and 
the protein backbone can be targeted. Oxidative modification of proteins can involve cleavage of the 
polypeptide chain, modification of amino acid side chains as well as conversion of the protein to 
derivatives which are highly sensitive to proteolytic degradation [15 - 17]. As a result of this change, 
the affected proteins lose their biochemical functionality, and finally lead to protein aggregation [18, 
19]. More and more evidences have shown that protein oxidation is implicated to many 
neurodegenerative diseases such as morbus Alzheimer [20 - 22] and Parkinson [23], as well as a 
wide range of age-related problems [17, 24, 25]. 
 
1.2 Methionine oxidation 
Among all amino acid residues of proteins, the two sulfur-containing amino acids, cysteine (Cys) and 
methionine (Met), are easily oxidized even under mild conditions [26, 27]. Most Met residues are 
found in the hydrophobic core of proteins due to their strong hydrophobicity. Such Met residues are 
fairly protected from ROS, while the surface exposed Met residues are more susceptible to oxidation 
[28, 29]. The oxidation of Met generates methionine sulfoxide [Met(O)] which is more hydrophilic 
than Met, and this often results in an alternation of protein structure.  
Both free Met and its protein bound form can be oxidized. Upon oxidation to the sulfoxide, the sulfur 
atom becomes a chiral center. Thus, Met(O) exists as a pair of diastereomers, i.e. L-methionine-(S)-
sulfoxide [Met-S-(O)] and L-methionine-(R)-sulfoxide [Met-R-(O)]. There is no evidence for the 
preferential formation of one diastereomer of Met(O) over the other in proteins or in its free form 
during oxidation, except for the oxidation induced by flavin-containing monooxygenase 3 [30, 31]. 
Although Met(O) is a fairly stable product, the sulfur can be further oxidized to a sulfone by strong 
oxidants leading to an irreversible product, which occurs to a low extent also under biological 
conditions [32]. In contrast, cells have developed a system for Met(O) reduction. Methionine 
sulfoxide reductases (Msrs) are the enzymes for this function and thus are at present considered as 





1.3 Methionine sulfoxide reductase 
Protein-bound as well as free Met(O) can be reduced by methionine sulfoxide reductases (Msr) 
[33, 34]. For the reduction of the individual diastereomers two types of Msr enzymes, MsrA and 
MsrB, exist. They share little sequence homology but possess mirror-like relationships of their active 
sites [35]. MsrA reduces Met-S-(O) bound in proteins or as free amino acid [36 - 38]. MsrB proteins 
reduce the Met-R-(O) but display only low activity for the reduction of free Met-R-(O) [38, 39]. In 
addition, an enzyme named free methionine-(R)-sulfoxide reductase (fRMsr) has been described in 
bacteria [40, 41] and fungi [42], which specifically reduces free Met-R-(O) (Fig. 2). Msr enzymes 












Research suggests that MsrA concentrations decline in different rat tissues during aging [44]. In 
addition, lower levels of MsrA are also found in Alzheimer [45] and Parkinson [46] patients. 
Deletion of Msr or loss of enzyme activity reduces the lifespan in mice [33], whereas its 
overexpression was shown to extend the lifespan of fruit flies [47]. Furthermore, Msr may also 
regulate protein function by controlling the redox state of critical Met residues [48 - 50]. In terms of 
calcium/calmodulin (Ca2+/CaM)-dependent protein kinase, the protein activity is enhanced by 
L-Met 
L-Met-(S)-sulfoxide L-Met-(R)-sulfoxide 
MsrA   MsrB 
ROS 
Fig. 2: Methionine oxidation and methionine sulfoxide reduction 
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angiotensin II-induced oxidation of paired regulatory domain Met residues in the absence of 
Ca2+/CaM, while this is reversed via Met(O) reduction by MsrA [48].  
Interestingly, recent studies indicate that bacterial MsrA can also function as a stereospecific oxidase 
which oxidize Met77 to Met-S-(O) specifically in calmodulin as well as several model substrates in 
the absence of reductant, whereas such behavior could not be observed for bacterial MsrB of fRMsr 
[51, 52]. Other studies showed that Met-S-(O) epimerase may exist. Kumar et al. observed a yeast 
mutant lacking MsrA and MsrB but overexpressing MsrB form Drosophila melanogaster was able to 
grow on Met-R-(O) medium as well as Met-S-(O) medium [53]. This is also indicated by the fact that 
MsrA and MsrB double knock-out mice showed growth deficiency when fed with Met restriction, 
while the deficiency can be compensated given that one gene is present [54]. This seems especially 
important to the endoplasmic reticulum because only MsrB can be found in this organelle [55, 56]. 
 
1.3.1 Msr variants and cellular locations  
There is one gene encoding MsrA in mammals including humans [57]. The most abundant MsrA 
form expressed from this gene contains a typical N-terminal mitochondrial signal peptide. The 
mouse protein containing a mitochondrial signal peptide is found targeting to the cytosol and nucleus 
as well as to mitochondria [58]. In contrast to a single MsrA gene, three separate MsrB genes have 
been identified in mammals [43, 56]. The first known MsrB, MsrB1, is a selenoprotein and localized 
in mitochondria and the mucleus [56]. MsrB2 (also known as CBS-1) contains a cysteine residue 
instead of the selenocysteine and an N-terminal signal peptide exclusively targeting to mitochondria 
[56]. The third mammalian MsrB, MsrB3, also contains a cysteine residue in the active site, but 
develops into two forms, MsrB3A and MsrB3B by alternative first exon splicing [56]. MsrB3A 
contains an endoplasmic reticulum (ER) signal peptide at the N-terminal and an ER retention signal 
at the C-terminal, whereas MsrB3B contains a different signal peptide at the N-terminal and is 
targeted to mitochondria [34, 56]. 
Findings show that MsrA and MsrB are present in multiple cellular locations indicating that a 
methionine sulfoxide reduction system is maintained in different compartments in mammalian cells 
for the repair of oxidized methionine residues [34] (Fig. 3). The fact that three MsrB variants located 
in different cellular compartments may imply that each protein has a role in antioxidant defense [34]. 
The simultaneous presence of MsrA and MsrBs in multiple compartments suggests that these two 




MsrB in ER, it could be speculated that a Met-S-(O) epimerase may exist, which makes Met-S-(O) 













1.3.2 Catalytic mechanism of Msrs 
The catalytic mechanism of different Msrs is quite similar and involves the interaction of the 
methionine sulfoxide substrate with the catalytic cysteine residues [38, 61, 62]. The number of 
cysteine involved in catalytic cycle may vary between organisms. Most Msrs possess two Cys 
residues, one for catalysis and the other for recycling of the Msr [63, 64]. Fig. 4 shows the general 
catalytic mechanism of Met(O) reduction in terms of MsrA catalysis. The catalytic process requires 
reductants in order to regenerate the reduced Cys residues in Msrs. The oxidoreductases thioredoxin 
(Trx) and glutaredoxin (Grx) are physiological reductant of Msrs. In vitro, dithiothreitol (DTT) also 
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Fig. 3: Msr variants and cellular locations (adapted from Kim 2007). 
 















Serine substitution of the catalytic Cys of Msrs completely inhibits enzyme activity suggesting that 
the essential function of the catalytic Cys in Msr function [65]. In contrast, serine substitution of the 
recycling Cys still allows the reduction of Met(O) but not the regeneration of the enzyme [67]. 
Furthermore, some Msrs have evolutionarily replaced the catalytic Cys by a selenocysteine (Sec), 
leading to a higher chemical reaction rate with electrophiles as well as a higher reduction potential 
compared to Cys [68, 69]. This may contribute to the increased redox activity of seleno-enzymes 
compared to the Cys-containing enzyme analogs [70].   
 
1.3.3 Substrate specificity  
Although MsrA and MsrB enzymes have distinct three-dimensional structures, determination of the 
protein structure from various organisms indicates a mirror-like relationship between the two 
enzymes active sites, in which a Trp faces the catalytic Cys and allows the docking of the substrate 
in the optimal position for the reduction [35, 38, 71] (Fig. 5). This mirror-like relationship ensures 


























Fig. 4: General catalytic mechanisms of MsrA. In the first step (Ⅰ), the substrate, Met-S-(O), is reduced 
by MsrA. The catalytic Cys of MsrA, CysA (shown in red), attacks the sulfur atom of Met(O) 
leading to a sulfenic acid intermediate. The following steps are to regenerate the enzyme. The 
nucleophilic attack of a recycling CysB (shown in blue) on the sulfur atom of the relatively unstable 
sulfenic acid intermediate results in the formation of disulfide bond (step Ⅱ). Finally, the CysA-
CysB disulfide bond is reduced by Trx in step Ⅲ and the Msr with reduced catalytic and reycycling 






contains two acidic residues (Asp134 and Glu99) in the active site compared to MsrB enzyme, which 
is thought to be related to the preference of MsrA for peptide substrates which compose positively 












MsrA has a broad substrate specificity and can reduce free Met-S-(O), protein-bound Met-S-(O) as 
well as other Met(O) derivatives, such as 4-N,N-dimethylaminoazobenzene-4’-sulfonyl (dabsyl)-
Met-S-(O) [53, 73, 74], N-acetyl-Met-S-(O) [75], 9-fluorenylmethyloxycarbonyl (Fmoc)-Met-S-(O) 
[76, 77] and ethionine-Met-S-(O) [78]. Even dimethylsulfoxide (DMSO) can serve as a substrate for 
MsrA [79]. MsrB is specific for protein-bound Met-R-(O) and Met(O) derivatives, but displays only 
low activity towards free Met-R-(O) [38, 39]. Additionally, fRMsr only catalyzes the reduction of 
free Met-R-(O) and does not reduce protein-bound Met(O) or derivatives [80, 81]. In support of the 
fact that MsrA and MsrB have dramatically different catalytic properties for the reduction of free 
Met(O), E.coli MsrA has been shown to possess a 1000-fold higher catalytic efficiency for the 
reduction of free Met-S-(O) compared to E.coli MsrB for the reduction of free Met-R-(O) [40]. 
Furthermore, human SK-Hep 1 cells failed to grow on free Met-R-(O) supplemented media without 
Met, whereas they grow well on the corresponding Met-S-(O) supplemented media [80].  
 
Fig. 5: Active-site models of A. nidulans MsrA and MsrB. (A) Stick representation of MsrA residues 
Cys52, Phe53, Trp54, Tyr87, Glu99, Tyr139, Asp134, and Cys200. (B) Sticks representation of 
MsrB active site residues Cys123, Arg121, His107, Try70 and Asn125. Atom color as follows: 
carbon in gray; nitrogen in blue; oxygen in red and sulfur in yellow. Adapted from [42]. 
1.4 Assays for Msr 
9 
 
Kinds of Met(O)-containing protein substrates have been reported recently [82]. Given the three-
dimensional structures of these protein substrates, only oxidized Met residuals located on the protein 
surface can be reduced, unless the oxidized Met residues positioned within the three dimensional 
structure provoke an unfolding of the protein [83, 84].  
Furthermore, some drugs containing a methylsufinyl group such as sulindac, mesoridazine or 
triclabendazole can only be reduced by MsrA, but not by MsrB, illustrating the broad substrate range 
of MsrA [85 - 88]. This also offers new insights into drug metabolism and may provide therapeutic 
opportunities for increased efficacy of drugs by utilizing a particular enantiomer instead of the 
racemic mixture.  
 
1.4 Assays for Msr  
To determine the activity of Msrs, several in vitro assays have been developed, including the direct 
detection of Met in the reduced/oxidized state and the indirect evaluation of the enzymatic activity 
by following the oxidation of the cosubstrate NADPH using a NADPH-coupled Trx system. A 
radiation assay was based on the reduction of N-acetyl-[3H]-Met(O) to N-acetyl-[3H]-Met, which is 
extracted into an organic solvent followed by scintillation counting [89, 90]. Reduction of [3H]-
Met(O) could also be analyzed by TLC [90]. HPLC-based methods were developed utilizing labeled 
amino acids such as Fmoc-Met(O) [76] or dabsyl-Met(O) [36, 73, 90] as substrate and DTT as 
reducing agent. Dabsyl-Met(O) was also used as substrate in a photometric assay where the product 
dabsyl-Met was extracted into organic solvent [91, 92]. Another type of photometric assay followed 
the oxidation of NADPH in a coupled reaction using the Trx reduction system with various 
substrates [75, 79] (Fig. 6). This method is based on the fact that MsrA coupled with Trx reductase 
catalyzes the reduction of Met(O) and simultaneously initiates the oxidation of NAPDH so that the 
enzyme activity could be evaluated by following the decrease of UV absorbance of NADPH at 340 
nm. However, this indirect assay is not specific, as it involves Msr enzymes, Trx and Trx reductase, 


















Detection methods also include mass spectrometric analysis, which is so far the only method that has 
been used to identify oxidized proteins and determine the extent of Met oxidation on a proteome-
wide scale [65]. It should be mentioned that the unavoidable Met oxidation during MS analysis due 
to the ionization process makes the observed Met oxidation imprecise [93 - 95]. The oxidation of 
Met in proteins could be globally analyzed immunologically by western blot as well, even though the 
exact site of oxidation cannot be identified in this approach [65, 96 - 98]. 
To study the stereospecificity of Met(O) reduction by Msr enzymes, the individual diastereomers 
dabsyl-Met-S-(O) and dabsyl-Met-R-(O) have been frequently used as substrates [36, 73]. Recently, 
Uthus developed a capillary electrophoresis (CE) assay for Msr enzymes based on the separation of 
the dabsyl-Met(O) diastereomers [99].   
 
1.5 Capillary electrophoresis 
CE is one of most efficient separation tools and has matured as a versatile and flexible analytical 
technique that combines simplicity, flexibility and high reproducibility [100]. In CE, the analyte 
separation is carried out in a capillary with an inner diameter of 20 to 100 μm which allows the 
application of high voltage due to dissipation of Joule heat. UV- or the laser induced fluorescence 
detection is often applied as detection mode and carried out on-column. The hyphenation to a mass 
spectrometer to CE has become a routine as well. CE has proved useful for the separation of small 
Fig. 6: Coupled reaction for the reduction of methyl sulfoxide compounds catalyzed by MsrA. 
NADPH is the hydrogen donor for the reduction of oxidized Trx [Trx(O)] by thioredoxin 
reductase (TrxB). The reduced Trx reduces methionine sulfoxide containing compounds by 
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molecules such as amino acids, drugs, inorganic ions, as well as the analysis of large molecules 
including proteins, DNA restriction fragments, and even whole cells and virus particles. 
The separation of analytes in CE is based on the difference of the electrophoretic mobilities of 
charged molecules upon the application of high electric field strength. The mobility of an analyte is 
determined by the electrophoretic mobility of a particle, μep, as a function of charge, q, and the size 







=                                                                                                                                           (1) 
 
η is the viscosity of the background electrolyte. In case of acidic or basic analytes, the charge is a 
function of the pKa of the analytes and the pH of the electrolyte solution. The charge-to-size ratio is 
also generally referred to as charge density. 
A fundamental constituent of CE is the electroosmotic flow (EOF), which is the bulkflow of the 
liquid in the capillary formed as a consequence of the surface charge on the interior capillary wall. 
The EOF has a plug-like flow profile compared to the parabolic flow profile of pressure driven 
chromatographic techniques, which makes CE a high resolution technique. The mobility of the EOF 
is a function of the permittivity of the electrolyte solution, ε, and the zeta-potential, ζ, resulting from 





=EOF                                                                                                                                           (2) 
 
Consequently, the effective mobility of a solute is the sum of both electrophoretic forces, μep and 
μEOF, according to: 
 
EOFepeff µµµ +=                                                                                                                                  (3)        
 
Under normal conditions (that is, a negatively charged capillary surface), the magnitude of EOF can 
be more than an order of magnitude greater than the mobility of analytes so that the EOF is able to 




the capillary wall (by pH or additives) can decrease or even reverse the EOF to achieve opposite 
movement direction of anions and cations.   
 
1.5.1 Modes of operation 
The versatility of capillary electrophoresis is derived from the numerous modes of operation. The 
main separation modes in CE are capillary zone electrophoresis (CZE), capillary electrokinetic 
chromatography (CEKC), capillary electrochromatography (CEC), capillary isotachophoresis, 
capillary gel electrophoresis and capillary isoelectric focusing. For the most part, the different modes 
can be realized simply by altering the buffer composition, which makes CE a very flexible and cost-
effective technique. The CZE and CEKC are most commonly used CE modes and will be discussed 
here in more details. 
 
1.5.1.1 CZE 
CZE is the simplest form of CE, in which a capillary is filled with an electrolyte and the sample is 
introduced at the inlet as a narrow zone. As an electric field is applied, each component in the sample 
zone migrates according to its own apparent mobility, which depends on the charge-to-size ratio of 
this chemical compound (see equation 3). Separation of both anionic and cationic solutes is possible 
by CZE in one analysis.  
 
1.5.1.2 CEKC 
CEKC is based on electrophoretic migration as well as on the chromatographic separation principles. 
Many selectors can be added to the background electrolyte (BGE), such as surfactants [101, 102], 
cyclodextrins (CDs) [103 - 105], antibiotics [106], crown ethers [107], ligand exchangers [108] and 
proteins [109]. In this mode, the buffer additives represent a so-called pseudostationary phase that 
may possess its own electrophoretic mobility. The transport of the analyte and/or the analyte-additive 
complex to the detector is accomplished by electrokinetic phenomena. The separation is based on the 
different partitioning of the analytes between pseudophases and aqueous phase [110]. Therefore, the 
selector-based separation is a hybrid of electrophoresis and chromatography thus termed as 
electrokinetic chromatography. The presence of the additive in the BGE also allows a rapid change 
of the experimental conditions enabling rapid method development.  
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Micellar electrokinetic chromatography (MEKC) 
MEKC is a mode of CEKC, in which surfactants such as sodium dodecyl sulfate (SDS) are added to 
the buffer solution. At a concentration above the critical micelle concentration (CMC), the surfactant 
molecule aggregates and micelles are formed. The hydrocarbon tails (hydrophobic) will be oriented 
toward the center of the aggregated molecules, whereas the polar head groups point outward. Fig. 7 
schematically shows a typical separation by MEKC. During the electrophoretic migration, the 
analytes partition differentially between the micelles and the running buffer resulting in different 
migration velocities so that the analytes can be separated. Therefore, MEKC in not only effective for 
the separation of charged species but also for neutral compounds. Furthermore, it has also been 
applied for the separation of diastereomers due to slight difference of distribution coefficients 












CDs are cyclic oligosaccharides which consist of α(1,4)-linked D-glucose units obtained by the 
digestion of starch by certain Bacillus strains [114]. CDs are by far the most often applied chiral 
selectors for the separation of stereoisomers owing to their commercial availability, UV transparency 
and relatively low prices. The basic structures comprise six, seven, or eight glucopyranose unites 
attached by α-1,4 linkages and are referred to as α-, β-CD and γ-CD, respectively (Fig. 8).  
 
Fig. 7: Illustration of a separation by MEKC. A, B+, C- are neutral, positively charged and negatively 







    
 
    
  
  
   
  
  
      
 
    
  
  




    
 
    
  
  































The interior of the CD is hydrophobic. The narrow rim contains the primary 6-hydroxyl groups of 
the glucose molecules while the wider ring is formed by the secondary 2- and 3-hydroxly groups. 
The hydroxyl groups can be derivatized resulting in a large variety of CD derivatives with uncharged 
or charged substituents. Complex formation is believed to occur via the inclusion of lipophilic 
moieties of the analytes in the hydrophobic cavity with secondary interactions including hydrogen 
bonding or dipole-dipole interactions with the hydroxyl groups or polar substituents [105, 115]. In 
case of charged CDs, ionic interactions will contribute to the binding.  
 
Crown ethers as additives 
Crown ethers are macrocyclic compounds. The polyether ring system in the structure forms a cavity 
which is able to include alkali and alkaline earth metal cations, ammonium and protonated 
alkylamines [116 - 118]. Kuhn et al. were the first to report the use of a chiral 18-crown-6 
tetracarboxylic acid (18C6H4) as a chiral recognition agent to separate the enantiomers of a variety 
of primary amino compounds. In the subsequent study [119], an interesting synergistic effect was 
observed with the simultaneous use of α-CD and 18C6H4. Later, the achiral crown ethers such as 18- 
crown-6 (Fig. 9A) and Kryptofix® 22 (Fig. 9B) were also used in the combination with different CDs 
to improve the separation [120 - 125].  
Fig. 8: Structures of native cyclodextrins. 










1.6 Capillary electrophoretic enzyme assays 
1.6.1 Off-line assays 
CE has been frequently applied to enzyme analysis due to advantages such as high separation 
efficiency, rapid, low cost and integration of various detection modes [126 - 130]. Initially, it was 
used only as a separation tool in pre-capillary assay, in which the incubation of substrate, cofactor, 












































Either the enzyme or the substrate is added to start the reaction. After incubation for an intended 
period of time, the reaction is most often quenched before subjected to CE analysis. Centrifugation 
of precipitated proteins is usually performed to prevent capillary clogging before sample injection. In 
pre-capillary assays, only the determination of substrate(s) and/or reaction product(s) are performed 
by means of CE, so that this method can be classified as an off-line assay. It is also the most 
frequently used method for the CE-based enzyme analysis. Since Krueger et al. used CE for the first 
time to determine the activity of endopeptidase Arg-C [131], numerous CE methods have been 
developed for many enzymes of diverse actions and origins. 
 
1.6.2 In-capillary enzyme assays 
To further miniaturize the CE assay, the incubation and the separation can be integrated into a single 
capillary [130, 132 - 134], because a capillary tube can serve as (i) a microreactor to carry out a 
reaction in a nanoliter volume, (ii) a separation column to separate the substrate and reaction product 
and (iii) a detection cell to quantify the substrate as well as the product. By integration of all reaction 
and analysis steps into a single capillary, in-capillary (on-line) assays allow a higher degree of 
automation and realize a further miniaturization of the analytical system. 
In order to perform an in-capillary assay, the enzyme can be either immobilized onto the capillary 
wall or injected as plugs in solution [126, 128, 134 - 136]. In order to prepare immobilized enzyme 
bioreactors, many approaches can be employed including physical adsorption, ionic binding, 
covalent binding and sol-gel entrapment [134]. Although immobilization of the enzyme in the 
capillary results in a longer enzyme lifetimes, this method limits the buffer choices especially when 
the incubation buffer is not compatible with the separation buffer.  
The first in-capillary assay by injecting enzyme plugs was described by Bao and Regnier [132] and 
was performed by injecting a zone of enzyme into a capillary filled with a solution of the substrate. 
The product is continuously formed during the electrophoretic mixing of enzyme and substrate. This 
method was latter defined as the long contact of electrophoretically mediated microanalysis 
(EMMA) [130, 137] (Fig. 11A), which also known as the continuous or zonal EMMA. The enzyme 
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Fig. 11: Schematic illustration of the commonly used modes of EMMA for enzymatic assays. (A) Long 
contact mode; (B) Short contact mode; (C) At-inlet reaction mode (longitudinal diffusion) and (D) 
partial filling plug-plug mode. Zones of the reagents are labeled as follows: IB, incubation buffer; 
E, enzyme; S, substrate; P, product. Plus “  ” and minus “  ” markes mean that at the given step, 




In contrast to the long contact mode, the plug-plug EMMA mode was developed by injection of 
consecutive plugs of reactants into the capillary, which is also known as the short contact mode (Fig. 
11B). The enzymatic reaction is initiated by the application of an electric field since the zones 
interpenetrate due to the difference in their electrophoretic mobilities. Normally, the first injected 
plug between enzyme and substrate should be the one with the lower electrophoretic mobility to 
ensure plug overlap [138]. After the electrophoretical mixing, the capillary is normally left for a 
period of time without voltage for a zero potential amplification and followed with CE separation 
[130, 139].  
In the plug-plug mode of EMMA, the mixing of the zones could also be achieved by simple diffusion 
at the inlet of the capillary, in which longitudinal diffusion between short plugs (Fig. 11C) [135] 
or/and transverse diffusion of laminar flow profiles (TDLFP) [140] generated by pressure is/are 
contributing to the zone mixing. This is also termed “at-inlet reaction mode” and is especially 
suitable for enzymes not resistant to an electric field. 
In many cases, the separation buffer may be incompatible with the incubation conditions due to pH, 
the presence of additives, etc., which may impair the enzyme. In this case, an additional plug of 
incubation buffer can be injected first to protect the enzyme from separation buffer. This is termed 
“partial filling mode” in EMMA [141] (Fig. 11D). The plug-plug mode has been the most commonly 
used EMMA mode due to the fact that less amount of reactant is required compared to the long 
contact EMMA mode. 
EMMA offers a simple way for the study of enzyme reactions with in-capillary assays, including 
screening of enzyme activities, enzyme kinetics, and inhibitor studies [142 - 146]. The application of 
EMMA method can also be extended to in-capillary derivatizations [130] as well as investigation of 













2 Aims and scope 
MsrA and MsrB are repair enzymes that reduce Met(O) residues to Met in a stereospecific manner. 
The enzymes have been extensively studied, and several assays have been reported for the 
determination of the in vitro activity (see chapter 1.4) However, less attention has been paid to 
stereospecific methods for Msr enzymes provided the fact that MsrA and MsrB work on opposite 
diastereomers of Met(O). As a powerful analytical technique, CE has unique advantages for the 
separation of structurally close compounds, which makes CE an ideal tool for the study of the 
stereospecificity of Msr enzymes. 
Hence, the aim of this work was the development of stereospecific CE methods for Msr enzymes that 
allow to study and characterize recombinant enzymes. The substrates should comprise free Met(O), 
Met(O) derivatives as well as Met(O) containing peptides. Consequently, the specific objectives of 
the research included:  
1. Development of an off-line assay using free Met(O) as substrate. Upon incubation, the amino 
acids should be derivatized with dabsyl chloride because the dabsyl-Met(O) diastereomers can be 
separated by MEKC [99].    
2. Development of an in-capillary assay in order to further miniaturize the system. Fmoc-Met(O) 
should be used as substrate because it is commercially available and has been applied as Msr 
substrate in the literature [76, 77].  
3. Development of an off-line assay using Met(O-containing peptides as substrate. Because the 
separation of Met(O) peptide diastereomers has not been reported previously, the separation 
conditions should be also systematically studied.    
4. To study the substrate specificity of MsrA mutants towards peptide substrates in comparison to 
the wild-type enzyme. A previous non-stereospecific HPLC-based had indicated that peptide 
substrates with positively charged amino acid residues adjacent to Met(O) are preferentially 
reduced by MsrA [42]. The enzyme mutants had been expressed in order to identify the 
importance of amino acids for the binding of the substrates [42]. Molecular modeling studies 
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Dabsyl chloride was recrystallized from acetone prior to use. All other chemicals were of the highest 
purity available and used without further purification.  
 
Enzymes 
All recombinant enzymes including human MsrA enzyme (hMsrA), human MsrB2 enzyme 
(hMsrB2), fungal fRMsr, fungal MsrA and its mutants, EQ, DN and DE were provided from the 
group of Prof. S.H. Heinemann and Dr. R. Schöherr (University of Jena, Germany).  
The cloning and construction of a 6xHis-Tag fusion construct of Msr enzymes were described 
previously [148, 149]. The proteins were overexpressed in Escherichia coli (strains BL21 or M15) 
and isolated using Ni-nitrilotriacetic acid-Agarose [150]. The QuikChange II Site-Directed 
mutagenesis Kit (Agilent technologies, USA) was used for the mutations. The mutant’s information 
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The purity of the enzymes was confirmed by SDS-PAGE. Solutions of the Msr enzymes were 
prepared at a concentration of 1 mg/mL protein in Tris buffer (pH 8.0)/glycerol (2:1, v/v) and stored 















MsrA Position99 Position134 
wt (ED) Glu (E) Asp (D) 
EQ Gln (Q) Asp (D) 
DN Glu (E) Asn (N) 
DE Glu (E) Glu (E) 
Balances 
Centrifuge 
Filters (0.2 μm) 
Incubator 
Lyophilizer 
Milli-Q Direct 8 system 
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Capillary electrophoresis  
CE experiments were performed on a Beckman P/ACE MDQ capillary electrophoresis system 
(Beckman Coulter, Krefeld, Germany) equipped with a UV-Vis diode array detector and a sample 
tray temperature control system set at 10 °C. Data analysis was carried out with 32 KaratTM software 
version 4.0. Fused-silica capillaries (BGB Analytik Vertrieb, Schloßböckelheim, Germany) with 75 
μm id, 375 μm od and 50 μm id, 363 μm od were used. Prior to use a fused-silica capillary, a new 
capillary was successively rinsed at a pressure of 138 kPa (20 psi) with 1 M sodium hydroxide for 20 
min, water for 10 min, 0.1 M sodium hydroxide for 20 min, water for 10 min, and the BGE for 10 
min. At the end of each day, the capillary was rinsed with 0.1 M sodium hydroxide for 10 min, water 
for 10 min, the BGE for 10 min and left in the BGE overnight. Between analyses, the capillary was 
flushed with 0.1 M sodium hydroxide for 3 min, water for 2 min, and the BGE for 3 min was 
applied. For a successive multiple ionic-polymer layer (SMIL)-coated capillary, it was coated 
according to [151] with minor modifications. Briefly, a new capillary was rinsed at a pressure of 138 
kPa with 0.1 M HCl for 15 min, 1 M NaOH for 40 min and water for 15 min. Subsequently, the 
capillary was rinsed with 5% (w/v) aqueous HDB for 15 min and left without application of pressure 
for 30 min. Finally, it was rinsed with a 3% (w/v) aqueous DS for 30 min and left for 30 min. Before 
the first use, the coated capillary was rinsed with the BGE for 30 min. Between runs, the capillary 
was flushed with water for 2 min and the BGE for 3 min. 
All buffers were prepared in Milli-Q water, filtered by a 0.2 μm membrane and degassed in 
ultrasonic bath. 
 
3.3 CE-based analysis systems 
CE-System 1  
This system served for the off-line Msr assay using free Met(O) as substrate. Met(O), Met and β-Ala 










50/60.2 cm, 75 μm id, SMIL-coated capillary 
35 mM NaH2PO4, pH 8.0, 25 mM SDS 
25 kV/20 °C 
436 nm 
3.4 kPa, 3 s 
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The buffer was prepared by dissolving 35 mM NaH2PO4 in 1000 mL of water, adjusted to pH 8 
using 1 M NaOH followed by the addition of solid SDS to achieve a SDS concentration of 25 mM. 
The derivatization of the amino acids with dabsyl chloride was performed according to [152] with 
minor modifications. For method development, 100 μL of standard solutions containing 1 mM Met, 
3 mM Met(O) and 0.5 mM β-Ala as internal standard in 150 mM sodium bicarbonate buffer, pH 9, 
were mixed in a 1 mL Reacti Vial with 200 μL of a 8.5 mM solution of dabsyl chloride in acetone. 
The mixture was heated at 70 °C for 15 min. Subsequently, the vials were put in ice for 5 min. The 
organic solvent was removed by a gentle stream of nitrogen at room temperature, the residue was 
frozen at –80 °C and lyophilized. The residue was then reconstituted in 250 μL 20% (v/v) aqueous 
methanol followed by centrifugation at 5000 g for 15 min. The supernatant was analyzed or stored at 
–20 °C. Samples for method validation and the Msr incubations were diluted with an equal volume 
of a 1 mM solution of β-Ala in 150 mM sodium bicarbonate buffer, pH 9.0. The mixture was 
vortexed and 100 μL were derivatized as described above for the standard solutions. 
 
CE-system 2 
This system was used for the separation the mixture of Fmoc-Met(O), Fmoc-Met and Fmoc-β-Ala in 






The BGE was prepared by dissolving 50 mM Tris in 1000 mL of water, adjusted to pH 8.0 using 1 M 
hydrochloric acid followed by the addition of solid SDS to achieve a final SDS concentration of 30 
mM. 
The EMMA assay was performed in the partial filling mode. First, the capillary was rinsed with the 
BGE for 3 min. Subsequent plugs were injected at a pressure of 3.45 kPa (0.5 psi) in the order (i) 
incubation buffer for 8 s, (ii) 20 μg/mL enzyme in incubation buffer for 4 s, (iii) Fmoc-Met(O) in 
incubation buffer for 4 s, (iv) 20 μg/mL enzyme in incubation buffer for 4 s and (v) incubation buffer 






48/58.2 cm, 50 μm id SMIL-coated capillary 
50 mM Tris-HCl, pH 8.0, 30 mM SDS,  
25 kV/25 °C 
214 nm 
3.4 kPa, 4 s 
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0.4 mM. After each injection, the capillary inlet was dipped into a vial containing water to prevent 
cross-contamination of the solutions. The reaction was started by application of a voltage of 1 kV for 
30 s with the capillary ends immersed into the running buffer in order to mix the reactant zones. 
Thereafter, the capillary was left without voltage for a given time at 37 °C (zero potential 
amplification) followed by application of a voltage of 25 kV for 1 min to separate enzyme and 
substrate. Subsequently, the capillary was cooled to 25 °C within 2.5 min followed by application of 
the separation voltage of 25 kV. 
 
CE-system 3 







A 50 mM Tris-HCl buffer, pH 7.8, was prepared as previously described for CE-system 2. The 
appropriate amount of 15-crown-5 was first added to 50 mL of the Tris buffer, followed with the 















43/53.2 cm, 50 μm id, fused-silica capillary 
50 mM Tris-HCl, pH 7.85, 14.3 mg/ml sulfated β-CD, 5 
mM 15-crown-5 
25 kV/21.5 °C 
214 nm 







40/50.2 cm, 50 μm id, fused-silica capillary 
50 mM Tris-citric acid, containing CDs and/or crown ether (buf
fer pH and buffer composition see the chapter 4.4) 
25 kV/20 °C 
214 nm 
3.4 kPa, 4 s 
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50 mM Tris-citric acid buffers were prepared by dissolving the appropriate amount of Tris in water 
and adjusting to the pH with 1 M citric acid before completing to the desired volume with water. For 
buffers containing a single selector, the appropriate amount of CD or crown ether was added to 25 
mL of the respective Tris-citric acid buffer. After addition of the Kryptofix® diaza-crown ethers, the 
pH of the buffer was readjusted using a 1M solution of citric acid. For the buffers containing two 
selectors, the appropriate amount of the crown ether was first added to 50 mL of the Tris-citric acid 
buffer. As in the case of single selector-containing buffers, the pH of the buffer was readjusted using 
a 1M solution of citric acid after the addition of Kryptofix® diaza-crown ethers. Subsequently, the 
appropriate amount of a CD was added to 25 mL of the crown ether-containing Tris buffer.  
 
CE-system 5 







For preparation of a single selector-based buffer, the appropriate amount of CD or SDS was added to 
25 mL of the respective Tris-citric acid buffer. For the buffers containing two selectors, the 
appropriate amount of the SDS was first added to 50 mL of the Tris-citric acid buffer followed with 
the addition of appropriate amount of a CD to 25 mL of the SDS-containing Tris buffer. 
 
CE-system 6 










50/60.2 cm, 50 μm id, fused-silica capillary 
50 mM Tris-HCl, containing CDs and/or SDS (buffer pH and 
buffer composition see the chapter 4.5) 
25 kV/20 °C 
214 nm 
3.4 kPa, 4 s 









Buffer preparation refers to CE-system 5. 
 
CE-system 7 
This system was used for the validation and analysis of the incubation of ac-KDM(O)NK-Dnp and 





Buffer preparation refers to CE-system 4. 
 
CE-system 8 













50/60.2 cm, 50 μm id, fused-silica capillary 
50 mM Tris-HCl, pH 8.0, 15 mg/ml sulfated β-CD, 15 
mM SDS 
25 kV/20 °C 
214 nm 






50/60.2 cm, 50 μm id, fused-silica capillary 
50 mM Tris-HCl, pH 7.0, 12 mg/ml sulfated β-CD, 25 
kV/20 °C 
214 nm 






50/60.2 cm, 50 μm id, fused-silica capillary 
50 mM Tris-HCl, pH 7.5, 10 mg/ml sulfated β-CD, 25 
kV/20 °C 
214 nm 
3.4 kPa, 4 s 
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3.4 Method validation 
The assays were validated according to the International Conference on Harmonization (ICH) 
guideline Q2(R1) with regard to range, linearity, limit of detection (LOD), limit of quantitation 
(LOQ), precision and accuracy [153]. The ratio of the corrected peak areas of the analytes and the 
internal standard were used for quantification. For calibration, at least six generally equally spaced 
concentrations were used for each analyte and each concentration was analyzed three times. Intraday 
and interday precision were estimated by injection a sample six times a day and three times on three 
consecutive days, respectively. If not indicated otherwise, the LOD was calculated from the standard 
deviation of the y-intercepts, σ and the slope of the calibration curve, S, according to LOD = 3.3σ/S 
and LOQ = 10σ/S. The accuracy of the off-line assays was estimated in the calibration range by 
comparison of analytes prepared in enzyme matrix. In the EMMA assay, the accuracy was estimated 
also at the medium concentration level by comparison of injections of the plug sequence described in 
CE-system 3 but replacing the enzyme plug by incubation buffer. Each sample was analyzed three 
times.  
 
3.5 Enzyme incubations 
Msr enzyme reactions were carried out in 50 mM Tris, adjusted to pH 8.0 by the addition of HCl, in 
the presence of 20 mM DTT. Prior to the assay, the solutions containing enzyme and substrate were 
preincubated separately at 37 °C for 2 min. The reaction was started by addition of an appropriate 
amount of substrate stock solution prepared in water to achieve the desired concentration. If not 
indicated otherwise, enzyme reaction mixtures were incubated at 37 °C for 15 min and stopped by 
freezing at –80 °C. Blank sample was obtained by incubation without addition of substrate and 
control samples were conducted without the addition of enzyme. 
 
3.5.1 Free Met(O) as substrate 
For screening of Msr activity 20 μg/mL of Msr enzymes and 2 mM Met(O) were employed. For the 
characterization of hMsrA, 2 μg/mL of the enzyme was used in the incubation mixtures. The 
pHdependent assays were investigated at a concentration of 1 mM Met(O) in the presence of 2 
μg/mL hMsrA or fungal fRMsr and were incubated at 37 °C for 30 min. The time course was studied 
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at a concentration of Met(O) of 1.5 mM and the kinetic data were obtained using concentrations of 
Met(O) of 0.3 mM, 0.5 mM, 0.8 mM, 1 mM, 1.5 mM, 2 mM, 3 mM and 4 mM. The pH-dependent 
assays were conducted at a concentration of 1 mM Met(O) in the presence of 2 μg/mL hMsrA or 
fungal fRMsr and were incubated at 37 °C for 30 min. The samples were stored at –80 °C until 
derivatization for analysis.  
 
3.5.2 Fmoc-Met(O) as substrate (off-line assay) 
For screening of the Msr activity, concentrations of 20 μg/mL of Msr enzymes and 600 μM Fmoc-
Met(O) were employed. The kinetic data were obtained using 5 μg/mL of Msr enzymes and Fmoc-
Met(O) concentrations between 50 and 500 μM (corresponding to 25 to 250 μM of the individual 
diastereomers). The internal standard (4-aminobenzoic acid) was spiked to all incubations to yield a 
final concentration of 400 μM. Incubations were carried out at 37 °C for 10 min, quenched by the 
addition of 100 μL ice-cold methanol and 10 μL 3% (v/v) aqueous trifluoroacetic acid (TFA) and 
stored at –80 °C until analyzed. 
 
3.5.3 KIFM(O)K as substrate 
Each incubation was carried out in 100 μL volume. For screening of the Msr activity, concentrations 
of 15 μg/mL of Msr enzymes and 160 μM ac-KIFM(O)K-Dnp were used. The time course was 
studied at a concentration of 160 μM ac-KIFM(O)K-Dnp with 1 μg/mL hMsrA. Incubations were 
carried out at 37 °C for 9 min stopped by freezing at –80 °C. Before analysis, Fmoc-β-Ala was 
spiked into the thawed samples at a concentration of 70 μM. The determination of the Michaelis-
Menten kinetic parameters was carried out by varying the concentration of ac-KIFM(O)K-Dnp 
between 40 and 400 μM (corresponding to 20 to 200 μM of the individual diastereomers) in the 
presence of 1 μg/mL hMsrA and 7.5 μg/mL hMsrB2. 
 
3.6 Experimental design 
31 
 
3.5.4 KDM(O)DK, KDM(O)NK, KNM(O)DK, KFM(O)KK as substrates 
Each incubation was carried out in 100 μL volume. 5 μg/mL, 10 μg/mL and 15 μg/mL of fungal 
MsrA wild-type and the mutants EQ, DN and DE were investigated. The concentration of substrates, 
i.e., KDM(O)DK, KDM(O)NK, KNM(O)DK and KFM(O)KK were set at 180 μM, respectively. 
Incubations were carried out at 37 °C for 15 min stopped by freezing at –80 °C. Before analysis, 
Fmoc-β-Ala was spiked into the thawed samples at a concentration of 60 μM.  
 
3.6 Experimental design 
Modde 7.0 (Umetrics, Umea, Sweden) was used for the experimental design and statistical analysis. 
For screening and optimization models, the investigated factors were fitted using a polynomial 
function: 
 
                                                                                                   
 
where xi represents the factors to be optimized; y represents the response functions, i.e., peak 
resolution, and migration time of analytes. For each response y, the intercept bi, the main coefficients 
b1,…, n, the interaction coefficient b12,…, (n-1)n, the quadratic coefficients b11,…, nn, and the residual ε are 
calculated. The goodness of fitting (R2 = (total sum of squares − sum of squares for residuals)/total 
sum of squares) and the goodness of prediction [Q2 = 1 − (prediction residual sum of squares/total 
sum of squares)] were subsequently optimized. R2 and Q2 close to 1 describe an excellent 
model, Q2 > 0.5 a good model and Q2 > 0.1 indicates a significant model [154]. A fractional factorial 
response IV design was used for the identification of significant variables, while a five-level 
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3.7 Molecular modeling 
The molecular modelling was performed by the group of Prof. W. Sippl (University of Halle, 
Germany). The model was primary built based on the x-ray structure of Msr from N. meningitidis in 
complex with a substrate (Ac-Met-S-SO-NHMe) (PDB ID 3bqf). This template shares a 43 % 
sequence identity with the wild-type enzyme of A. nidulans. The obtained model was further refined. 
The C-terminus was remodeled (loop refinement) to be in better agreement with the C-terminus of 
yeast Msr (PDB ID 3pil), where the sequence identity of this part are higher. Docking was performed 
using the program GOLD 4.0 with default settings. Details about the GOLD program can be found 
elsewhere [155]. A scaffold constraint and an H-bond constrain were set to bias the results towards 
















4 Results  
Under physiological conditions, free and protein-bound Met is readily oxidized by ROS, leading to 
the formation of a pair of diastereomers, i.e., Met-S-(O) and Met-R-(O). For the reduction of the 
diastereomers, stereospecific Msr enzymes, MsrA and MsrB exist. MsrA enzymes reduce free and 
protein-bound Met-S-(O) while MsrB enzymes reduce protein-bound Met-R-(O) with little affinity 
for free Met-R-(O). The latter is reduced by free Msr (fRMsr). In order to develop stereospecific CE 
assays for the determination of stereospecificity of Msr enzymes, three frequently used substrates, 
i.e., free Met(O), Fmoc-Met(O), Met(O)-containing peptide, were applied.  
4.1 Off-line assay using free Met(O) as substrate  
In this part, the racemic mixture of Met-R-(O) and Met-S-(O) was applied as a natural substrate for 
the study of stereospecificity of recombinant Msr enzymes. Separation and detection of the 
diastereomers as well as Met were performed by capillary electrophoresis equipped with UV 
detection after sample derivatization.  
 
4.1.1 Method development and optimization 
The recently reported CE method by Uthus [99], which allowed the separation of the diastereomers 
of dabsyl-Met(O) and dabsyl-Met, was investigated as starting point. The method employed a 
50/60.2 cm, 75 μm id, uncoated fused-silica capillary, a 25 mM KH2PO4 buffer, pH 8.0, containing 
N-laurylsarcosine as BGE and a buffer containing also 25 mM SDS as conditioning solution. 
Although baseline separation of the dabsyl-Met(O) diastereomers was observed applying these 
conditions, we were not able to achieve reproducible migration times of the analytes. Since SDS is 
incompatible with potassium ions and leads to the formation of a precipitate [156], KH2PO4 was 
substituted by NaH2PO4, but this did not result in satisfactory reproducibility either. Upon variation 
of the experimental conditions, separation of the dabsyl-Met(O) diastereomers was observed in a 
bare fused-silica capillary using a 35 mM sodium phosphate buffer, pH 8.0, containing 25 mM SDS. 
Thus, the presence of N-laurylsarcosine in the background electrolyte was not essential for the 
separation of the Met(O) diastereomers. However, under these conditions a variation of the 
electroosmotic flow (EOF) and consequently varying migration times of the analytes were observed. 




6%, n = 10) but at the expense of long migration times (more than 30 min). Since the EOF proved to 
be variable, successive multiple ionic-polymer layer (SMIL) coating was investigated in order to 
provide a stable EOF. Thus, following the procedure of Katayama et al. [151], the fused-silica 
capillary was first coated with a layer of polybrene followed by a second layer of dextran sulfate. In 
combination with a 35 mM sodium phosphate buffer, pH 8.0, containing 25 mM SDS, reproducible 
migration times were observed. Thus after initially rinsing the SMIL-coated capillary for 30 min 
with the BGE, intraday run-to-run precision (RSD%) (n=6) was < 2.5% for the analytes and < 1.0% 
for the EOF, while interday precision (RSD%) (n = 3) was < 2.7% for the analytes and < 1.6% for 
the EOF. Typical resolutions of the Met(O) diastereomers of RS > 3.0 were achieved. A 
representative electropherogram of the separation of the Met(O) diastereomers, Met, as well as β-Ala 











Because polybrene plays a critical role in the coating efficiency [151], different batches of polybrene 
were evaluated in our study. Consequently, an effect of polybrene was observed in the present study 
as changing the batch of polybrene while keeping identical coating conditions led to different but 
still highly reproducible migration times. For example, the velocity of the EOF varied between 5.2 x 
10-8 m2V-1s-1 and 4.4 x 10-8 m2V-1s-1 for 4 different batches of polybrene. Subsequently, migration 
times in the range of 11 to 20 min were observed for the dabsyl-Met(O) diastereomers. Thus, 
changing the batch of polybrene in routine analysis of a validated method has to be considered with 
























Fig. 12: Electropherogram of a standard sample derivatized with dabsyl chloride. Met-S-(O) (1), Met-R-
(O) (2), β-Ala (3), Met (4). Experimental conditions: 50/60.2 cm, 75 μm id, coated capillary; 35 
mM sodium phosphate buffer, pH 8.0, containing 25 mM SDS; 25 kV; 20 °C; detection at 436 nm. 
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care. Furthermore, a dependence of the EOF on the dextran sulfate coating was also observed. Using 
a 5% (m/v) solution of polybrene for the first coating, a faster EOF was observed when a 5% (m/v) 
solution of dextran sulfate was employed for the second coating compared to the EOF found for a 
3% (m/v) or 1.5% (m/v) dextran sulfate solution. It may be speculated that complete coverage of the 
polybrene layer by dextran sulfate is necessary when using MEKC conditions because SDS may also 
adsorb to the polybrene layer. This may result in a change of the magnitude of the EOF as compared 
to a capillary with a "complete" dextran sulfate layer. 
The derivatization procedure using dabsyl chloride followed a published method [152] and was 
performed from samples identical to the incubation mixtures. The recrystallization of the commercial 
reagent proved to be essential for complete dissolution of the compound in acetone and reproducible 
results. Derivatization was performed at 70 °C for 15 min. Under these conditions, modification of 
pH (pH 8-10) or derivatization time (10-30 min) did not significantly affect the yield of the dabsyl 
amino acids as described in the literature [157].  
 
4.1.2 Method validation 
The method was validated according to guideline Q2(R1) of the International Conference on 
Harmonization (ICH) [153] with regard to range, linearity, and precision. To counteract injection 
errors, β-Ala was used as internal standard. The ratio of the corrected peak areas of the analytes and 
the internal standard was used for quantification. Msr enzyme may also react with dabsyl-Cl in 
derivatization process, which would make calibration in standard samples inaccurate. Therefore, 
calibration was performed in a matrix containing hMsrA enzyme identical to the incubations. The 
samples were kept on ice, spiked with six different concentrations of Met(O) and Met and 
immediately derivatized in order to avoid reduction of Met(O). All concentrations were analyzed in 










Table 2. Assay validation data using free Met(O) as substrate. 
Parameter          Met Met-S-(O) Met-R-(O) 
Range [mM] 0.15 – 2.0 0.15 – 2.0 0.150 – 2.0 
Linear equation y = 0.7794x - 0.0574 y = 0.9303x - 0.0073 y = 0.9147x - 0.0023 
Coefficient of determination, r2 0.9810 0.9998 0.9999 
Standard deviation of the slope 0.0003 0.0003 0.0002 
Standard deviation of the intercept 0.0328 0.0154 0.0132 
LOD / LOQ [μM] 100 / 150 50 / 150 40 / 150 
Repeatability (n=6)    
 Migration time (RSD) [%] 3.6 1.7 1.8 
 Corrected peak area (RSD) [%] 2.9 1.6 1.7 
Interday precision (n=3)    
 Migration time (RSD) [%] 2.4 2.8 2.8 
 Corrected peak area (RSD [%]) 1.5 1.1 1.0 
Accuracy (mean ± SD, n=3) 77.5 ± 3.6 101.9 ± 13.3 106.9 ± 9.8 
 
In the range 0.15 to 2.0 mM good linearity with coefficients of determination (r2) of at least 0.9998 
was observed for the Met(O) diastereomers, while only a coefficient of 0.9810 was found for Met. 
LODs (3.3σ/slope) were estimated at 0.04, 0.05 and 0.1 mM for the Met-R-(O), Met-S-(O) and Met, 
respectively. The accuracy of the analytes was estimated by comparison of analyte samples prepared 
in enzyme matrix immediately followed by derivatization with pure standards prepared in Tris buffer 
(pH 8.0). Analyte accuracy ranged between 77.5 ± 3.6 % and 101.9 ± 13.3 % at a concentration of 
0.5 mM of the compounds. Because validation was performed from samples identical to the 
incubation conditions and not from aqueous standard solutions, accuracy is already included in the 
data and was, therefore, not assessed in further detail. Intraday and interday precision were estimated 
by injecting samples containing 0.75 mM of the individual Met(O) diastereomers [1.5 mM Met(O)], 
0.5 mM β-alanine and 0.5 mM Met six times a day and three times on three consecutive days, 
respectively. The relative standard deviations (RSD) never exceeded 4% in case of migration times 
and 3% for the peak area ratio analyte/internal standard. 
 
4.1.3 Enzyme incubations 
To prove the applicability of the MEKC assay for quantitative analyses of enzymatic reactions, two 
Msr enzymes with inverse substrate stereospecificities, i.e. hMsrA and the fungal fRMsr protein, 
were investigated. Enzyme reactions were carried out in 200 μL of 50 mM Tris-HCl, pH 8.0, in the 
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presence of 20 mM DTT, at 37 °C for 15 min. In standard reactions, Met(O) at a concentration of 2 
mM was incubated in the presence or the absence of one of the enzymes and the reactions were 
stopped by freezing at –80 °C until derivatization. Fig. 13 shows the electropherograms obtained for 
the enzymes in comparison to a control sample in the absence of enzyme. The blank sample was 
obtained by incubation without addition of substrate. The utility of the assay for the determination of 
the stereospecificity of the reductases towards the diastereomers of Met(O) is clearly illustrated. In 
accordance with the literature, hMsrA only reduced Met-S-(O) [34, 39] while the diastereomer Met-
R-(O) was converted by fRMsr [40, 41]. Furthermore, the product Met could only be detected in the 










Investigations of optimum pH for incubations 
The optimum pH was screened for hMsrA and fungal fRMsr. The reactions for Msrs were carried 
out for 30 min at 37 °C with free Met(O) and DTT as a reductant. The incubations were performed in 
the pH range from 5.5 to 9.5. The reactions were stopped and derivatized before subjected to CE 
analysis. The data revealed that the optimum pH was 8.0 at which both, hMsrA and fungal fRMsr, 
showed the highest activity (Fig. 14). The tested Msrs were inactive at pH 6.0 or below. Human 
MsrA showed almost 50% activity at pH 7.5, while fungal fRMsr showed only 30% activity at this 
pH. Both enzymes showed a pronounced decrease of activity at a pH higher than 9.0. 
 
 
Fig. 13. Electropherograms of incubations of a blank sample in the absence of analytes (a), a control 
sample in the absence of enzyme (b), an incubation of fRMsr (c) and an incubation of hMsrA (d). 
Met-S-(O) (1), Met-R-(O) (2), β-Ala (3), Met (4). For separation conditions see Fig. 12. 


































Time-dependent incubation and enzyme kinetics of hMsrA 
Subsequently, the assay was employed for the quantitative characterization of hMsrA. Fig. 15 shows 
the time course of the incubation of 2 μg/mL of the enzyme and 1.5 mM of Met(O). As it can be 
seen, in the incubations from 5 min to 25 min, the concentration of Met-S-(O) decreased with a 










Enzyme kinetics of hMsrA were subsequently determined. The plots of the initial velocities versus 
substrate concentration were fitted to the Michaelis–Menten equation using Origin 8.5 (OriginLab, 





















Fig. 14: pH dependent reduction of free Met(O) by hMsrA and fungal fRMsr. Reactions were carried out in 
50 mM Tris-HCl at the indicated pH value using 1 mM free Met(O) as substrate in the presence of 
20 mM DTT, 2 μg/mL Msr, at 37 °C for 30 min. 
Fig. 15: Electropherograms of the time-dependent reduction of Met-S-(O) by hMsrA. 1.5 mM Met(O) was 
incubated in the presence of 2 μg/mL hMsrA. Met-S-(O) (1), Met-R-(O) (2), β-Ala (3), Met (4). For 
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Northampton, MA, USA). Fig. 16 shows the dependence of the initial velocity of the sulfoxide 
reduction as a function of the Met-S-(O) concentration either following the decrease of substrate or 










The Michaelis-Menten kinetic parameters derived from the increase of Met peak and from the 
decrease of the Met-S-(O) peak are summarized in Table 3. The corrected area ratio of the decreased 
Met-S-(O) was calculated according to: 
 
 
where AMet-S-(O) and AMet-R-(O) represent the corrected peak areas of Met-S-(O) and Met-R-(O), 
respectively, and Aβ-Ala is the corrected peak area of the internal standard β-Ala. The decrease of 
Met-S-(O) was calculated by calibration curve according to the responsible corrected area ratio. 
    








  Met-S-(O) decrease(1) Met increase 
Km [μM] 411.8 ± 33.8 390.1 ± 47.3 
vmax [μM · min-1] 30.8 ± 1.9 26.1 ± 1.4 
Kcat [s-1] 6.4 ± 0.2 5.4 ± 0.3 
Kcat/Km [mM-1 · min-1] 960 840 

































Fig. 16: Initial velocity, vo, as a function of substrate concentration monitoring the decrease of Met-S-(O) 











4.2 EMMA assay using Fmoc-Met(O) as substrate 
Although the CE-based off-line enzyme assay is fast and consumes only a small amount of 
chemicals and enzymes, the incubation and analysis steps can be integrated into a single capillary 
leading to further miniaturization and automation. In order to perform on-line incubation, Met(O) 
derivatives are required as substrate which enable UV detection. Fmoc-Met(O) was selected 
because the compound is a commercially available amino acid used in peptide synthesis. Moreover, 
it has been reported that the compound is a substrate of MsrA [76, 77].  
 
4.2.1 Separation of FMOC-Met(O) diastereomers 
A 48/58.2 cm, 50 μm id, SMIL-coated capillary was used in order to provide a stable EOF and, 
consequently, reproducible migration times as found for the CE separation of FMOC-Met(O) 
diastereomers. Because in chapter 4.1, incubations of Msr enzymes were performed in Tris buffer, 
pH 8.0, the separation of Fmoc-Met(O) diastereomers and the product Fmoc-Met was attempted in 
a 50 mM Tris buffer, pH 8.0. No separation of the analytes was observed under these conditions. 
Subsequently, MEKC was applied since it was effective for the separation of dabsyl-Met(O) 
diastereomers (see chapter 4.1.1). Addition of 30 mM SDS to a 50 mM Tris buffer, pH 8.0, resulted 
in baseline resolution of the Fmoc-Met(O) diastereomers as well as separation of Fmoc-Met within 
18 min. Fig. 17 shows a electropherogram for a standard sample spiked with 4-aminobenzoic acid 
as internal standard. Migration times were stable due to the use of the SMIL-coated capillary. 












The presence of SDS in the buffer would impair the Msr enzymes. Therefore, the partial filling mode 
[141] was selected for the development of an in-capillary assay in order to separate enzyme and 
substrate solutions from the separation buffer by a bracket of incubation buffer containing 50 mM 
Tirs, pH 8.0, and 20 mM DTT. The mixing of substrate and enzyme zones can be achieved by 
diffusion [140, 158, 159] or by application of the mixing voltage for a short period of time [126, 139, 
160, 161]. Both approaches were tested using 20 μg/mL Msr enzyme and a concentration of Fmoc-
Met(O) of 0.6 mM. The capillary temperature was kept at 37 °C. For electrophoretically mediated 
mixing, 1 kV was applied for 40 s followed with 10 min zero potential incubation. The injection 
sequences “enzyme-substrate”, “substrate-enzyme” as well as “enzyme-substrate-enzyme” and 
substrate-enzyme-substrate” were evaluated. An injection sequence “enzyme-substrate-enzyme” was 
chosen for the diffusion method to ensure maximum diffusion of enzyme plugs with the substrate 
plugs. And the diffusion time was set at 10.6 min compared to electrophoretic mixing. The reduction 
of the substrate was monitored as a response for the mixing efficiency. A decrease of the resolution 
between the Met(O) diastereomers was observed for the injection sequence “substrate-enzyme-
substrate”. Therefore, this injection order was not further investigated. Fig. 18 shows that mixing by 
voltage generally resulted in higher substrate reduction, especially when the injection sequence 
“enzyme-substrate-enzyme” was applied. The injection sequence “enzyme-substrate” led to very low 
Fig. 17: Electropherogram of a standard sample containing 0.6 mM Fmoc-Met-(O), 0.3 mM Fmoc-Met 
and 0.4 mM 4-aminobenzoic acid. Experimental conditions: 48/58.2 cm, 50 μm id, SMIL-coated 
capillary, 50 mM Tris buffer, pH 8.0, containing 30 mM SDS, 25 kV, 25 °C, detection at 214 nm. 
Peak labeling: 1, Fmoc-Met-S-(O); 2, Fmoc-Met-R-(O); 3, 4-aminobenzoic acid; 4, Fmoc-Met. 

























substrate conversion probably because the substrate migrated faster than the Msrs so that the efficient 











Since the electrophoretic mobility of the enzymes is not known and cannot be determined in a 
reliable way, the mixing voltage and the time of voltage application cannot be calculated for known 
plug lengths of enzyme and substrate in order to ensure maximum plug overlapping [162]. Therefore, 
the injection sequence "enzyme-substrate-enzyme" was selected instead of optimizing the injection 
sequence “substrate-enzyme”. Because the substrate was sandwiched between enzyme plugs and all 
the solutions were prepared in incubation buffer, the length of reaction plugs was fixed using an 
injection pressure of 3.45×103 Pa (0.5 psi) for 4 s resulting in plugs of about 7 mm at 37 °C by CE 
Expert Lite calculator of Beckman Coulter. Different periods of time for the application of the 
mixing voltage of 1 kV were investigated between 0 and 90 s. The zero potential incubation was set 
at 10 min. 4-aminobenzoic acid at a concentration of 0.4 mM was included in the substrate solution 
as internal standard to compensate for injection errors by the CE instrument. Fig. 19 shows the 
results of sulfoxide reduction with regard to the time for the application of the mixing voltage, 
monitoring the corrected peak area ratio of the product Fmoc-Met and the internal standard. The 
highest substrate conversion was observed for a mixing time of 30 s for both, hMsrA and hMsrB2. 
Fig. 18: Evaluation of different mixing methods including (M1) zone diffusion for 10.6 min, with the 
injection sequence enzyme-substrate-enzyme; (M2) application of 1 kV for 40 s followed with 10 
min zero potential incubation, using the injection sequence enzyme-substrate-enzyme; (M3) 
application of 1 kV for 40 s followed with 10 min zero potential incubation, using the injection 
sequence substrate-enzyme; (M4) application of 1 kV for 40 s followed with 10 min zero potential 
































Separation of substrate and product at the incubation temperature of 37 °C resulted in frequent 
breakdown of the electric current. Therefore, a voltage of 25 kV was applied after the incubation for 
1 min in order to separate enzyme and substrate before cooling the capillary to 25 °C within 2.5 min 
with the voltage switched off. Finally, a separation voltage of 25 kV was applied. This procedure 
resulted in a stable CE system.  
Under the optimized EMMA assay conditions, effective reduction of Fmoc-Met(O) with the 
concomitant formation of Fmoc-Met was observed. The time course of an incubation of 0.6 mM 
Fmoc-Met(O) with 20 μg/mL hMsrA is shown in Fig. 20. It can be clearly seen that the (S)-
configured sulfoxide is reduced to Fmoc-Met while the concentration of Fmoc-Met-R-(O) remains 
unaffected illustrating the stereospecificity of the MsrA enzyme. Although not all substrate is 
converted the data clearly show that the activity of Msr enzymes can be effectively analyzed by the 
present EMMA assay. The reaction may either be followed by monitoring the decreasing 




Fig. 19: Time dependence of 1 kV voltage application on the peak formation of Fmoc-Met in the EMMA 
assay. After mixing, 0.6 mM Fmoc-Met-(O), 20 μg/mL hMsrA or hMsrB2 and IS were left for 10 
min zero potential incubation at 37 °C. The ratio of the corrected peak areas of the analytes and 
the internal standard were used for quantification; triangles, hMsrA; circles, hMsrB2. 
 





























Fig. 21A shows representative electropherograms of incubations of Fmoc-Met(O) in the presence of 
hMsrA (trace c) and hMrsB (trace d), respectively. No interference was observed from matrix 
components (trace a) and no reduction of the sulfoxide was observed in the absence of enzyme (trace 
b).  
For comparison an offline assay was also developed using the separation system developed for the 
in-line assay. 0.6 mM Fmoc-Met(O) was incubated with 20 μg/mL hMsrA or hMsrB2 in Tris buffer, 
pH 8.0, 20 mM DTT, at 37 °C for 10 min. The reaction was quenched by adding ice-cold methanol 
and aqueous TFA containing the internal standard 4-aminobenzoic acid to give a concentration of 0.4 
mM. The samples were subsequently analyzed by CE. Fig. 21B shows electropherograms obtained 
for both enzymes. Neither interference by endogenous compounds (trace a) nor substrate conversion 
in the absence of MsrA (trace b) was observed. hMsrA reduced Fmoc-Met-S-(O) (trace c) while 




Fig. 20: Analyte concentration as a function of incubation time in the EMMA assay. 600 μM Fmoc-Met-
(O) and 20 μg/mL hMsrA were incubated at 37 °C prior to application of the separation voltage 
as described in the experimental part. The ratio of the corrected peak areas of the analytes and 
the internal standard were used for quantification. Triangles, Fmoc-Met-S-(O); circles, Fmoc-
Met-R-(O); squares, Fmoc-Met. 
 
































4.2.3 Method validation 
The EMMA assay was validated according to the ICH guideline Q2(R1) [153] with regard to range, 
linearity, recovery and precision. The ratio of the corrected peak areas of the analytes and the internal 
standard were used for quantification. Experiments revealed no difference in peak areas when 
injecting sample solutions directly or between plugs as described in the EMMA procedure. 
Therefore, calibration was performed by direct injection of the standard solutions. The accuracy of 
the off-line assay was estimated by comparison of analytes prepared in enzyme matrix immediately 
followed by adding 100 μL ice-cold methanol and 10 μL 3% (v/v) TFA aqueous compared to 
analytes prepared in Tris buffer (pH 8.0). In the EMMA assay, accuracy was estimated by 
comparison of injections of the plug sequence described for the EMMA method in CE-system 3 in 
the chapter 3.3 but replacing the enzyme plug by incubation buffer. The validation data are 
summarized in Table 4. 
 
 
Fig. 21: Electropherograms Fmoc-Met(O) incubations in the presence of Msr enzymes in (A) the EMMA 
assay and (B) the offline assay. Blank sample in the absence of analytes (a), control sample in 
the absence of enzyme (b), incubation with hMsrA (c) and incubation with hMsrB (d). Peak 
labeling: 1, Fmoc-Met-S-(O); 2, Fmoc-Met-R-(O); 3, 4-aminobenzoic acid; 4, Fmoc-Met. For 
separation conditions see Fig. 17. 





















































Table 4. Assay validation data using Fmoc-Met(O) as substrate. 
Parameter Fmoc-Met Fmoc-Met-S-(O) Fmoc-Met-R-(O) 
Range [μM] 25 – 500 25 – 500 25 – 500 
Linear equation y = 0.0070x - 0.0133 y = 0.0078x + 0.0088 y = 0.0075x + 0.0036 
Coefficient of determination, r2 0.9993 0.9996 0.9995 
Standard deviation of the slope 0.0005 0.0007 0.0007 
Standard deviation of the intercept 0.0369 0.0291 0.0300 
LOD / LOQ [μM] 10 / 25 5 / 25 5 / 25 
Repeatability (n=6)    
 Migration time (RSD) [%] 1.5 0.9 1.0 
 Corrected peak area (RSD) [%] 2.0 1.0 1.4 
Interday precision (n=3)    
 Migration time (RSD) [%] 1.8 1.0 1.1 
 Corrected peak area (RSD [%]) 1.7 0.9 0.9 




99.8 ± 4.0 
97.1 ± 2.9 
 
98.0 ± 3.5 
97.9 ± 1.3 
 
94.7 ± 2.6 
98.3 ± 4.1 
 
For each analyte, linearity with coefficients of determination, r2, of at least 0.9993 w ere obtained in 
the range between 25 μM and 700 μM using equally spaced concentrations. The LODs (signal-to-
noise ratio = 3) were estimated at 5 μM for each Fmoc-Met(O) diastereomer and 10 μM for Fmoc-
Met, while the LOQs (signal-to-noise ratio = 10) were about 25 μM for all analytes. Intraday and 
interday precision were estimated by injection of samples containing 600 μM Fmoc-Met(O) and 300 
μM Fmoc-Met six times a day and three times on three consecutive days, respectively. Precision of 
migration times ranged between 0.9 and 1.5% within one day while interday precision ranged 
between 1.0 and 1.8%. For corrected peak areas intraday and interday precision varied between 1.0 
and 2.0% and between 0.9 and 1.7%, respectively. Accuracy for the assays was estimated at the 
concentration of 300 μM for each analyte. Values between 94.7 ± 2.6% and 99.8 ± 4.2% were found 
for the offline assay and values between 97.1 ± 2.9% and 98.3 ± 1.1% for the EMMA assay. 
  
4.2.4 Enzyme kinetics  
The Michaelis-Menten kinetic data were determined for hMsrA and hMsrB2 in the EMMA mode as 
well as in the off-line assay. Because of the generally lower conversion was observed in EMMA, 
higher amount of the enzymes were applied in the on-line incubations than in the off-line assay. It 
should be noted that since the exact volum for an on-line incubation is unkown, the concentration of 
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the enzyme contributing to the reaction cannot be defined as well. The incubation time of 10 min was 
identical in both assays. The increase of Fmoc-Met concentrations was determined for the 
quantification. Fig. 22 shows the dependence of the initial velocity of the sulfoxide reduction by 
hMsrA and hMsrB2 as a function of the substrate concentration in the EMMA assay. The Michaelis 
constants, Km, and the maximum velocities, vmax, were calculated by nonlinear regression and are 











Table 5. Comparison of Michaelis-Menten kinetic parameters of hMsrA and hMsrB2 using Fmoc-Met(O) as     
substrate in the EMMA and offline assays derived from the increase of Fmoc-Met concentrations. 
The data are expressed as mean ± SD (n = 3). 
 
Essentially identical values were determined in both assays illustrating the general suitability of the 
in-capillary assay for the determination of kinetic data of Msr enzymes. Because the exact quantities 
of the enzymes reacting with the substrates are not known in the case of the EMMA mode, kcat 
values could not be determined for this assay.  
Parameter EMMA assay Offline assay 
  hMsrA hMsrB hMsrA hMsrB 
Km [μM] 286.7 ± 33.0 115.9 ± 10.0 256.2 ± 27.9 105.7 ± 10.4 
vmax [μM · min-1] 1.49 ± 0.12 0.97 ± 0.03 1.59 ± 0.11 1.10 ± 0.04 
kcat [min-1] – – 7.95 ± 0.55 3.74 ± 0.14 

































Fig. 22: Initial velocity, vo, as function of substrate concentration (A) hMsrA and (B) hMsrB2 obtained from 






4.3 Off-line CE assay using a diastereomeric peptide substrate 
Met(O) derivatives such as dabsyl-Met(O) have been frequently applied as Msr substrates [163, 
164]. However, these Met(O) derivatives are not peptides so that they may not reflect the activity of 
Msr enzymes towards peptide-bound Met(O). Therefore, the aim of the present study was the 
development of a CE method based on separation of the diastereomers of a Met(O)-containing 
peptide. The dinitrophenyl (Dnp)-labeled N-acetylated pentapeptide KIFM(O)K was selected 
because it has been shown to be a substrate for Msr enzymes [149, 165].  
 
4.3.1 Evaluations of initial separation conditions 
Since the substrate KIFM(O)K and the reduced peptide KIFMK are basic peptides due to the 
presence of two Lys residues, the separation of the peptides was attempted in a 43/53.2 cm, 50 μm 
id, fused-silica capillary using Tris-based background electrolytes in the pH range 2.5 - 9.5. 
However, no separation between KIFM(O)K and KIFMK was observed in this pH range. 
Subsequently, neutral and charged CDs were evaluated as buffer additives at a concentration of 15 
mg/mL in a Tris-citric acid buffer, pH 2.5. While partial or baseline separation between KIFM(O)K 
and KIFMK was observed in the case of β-CD, methyl-β-CD and carboxymethyl-β-CD, the 
KIFM(O)K diastereomers could not be resolved. The analytes could not be detected within 60 min 
the presence of 5 mg/mL sulfated β-CD under normal as well as reversed polarity of the applied 
voltage. Therefore, the pH of the background electrolyte was raised to 8.0 in order to increase the 
EOF and thereby decrease the migration time and the CD-analyte interaction time. In the presence of 
10 mg/mL sulfated β-CD in a 50 mM Tris-HCl buffer, pH 8.0, separation of all analytes was 
observed with RS = 2.5 for the resolution of KIFMK and KIFM-R-(O)K and RS =1.5 for the 
separation of the Met(O)-peptide diastereomers under normal polarity conditions. Increasing the 
concentration of sulfated β-CD to 25 mg/mL resulted in RS = 2.5 for the resolution of the 
diastereomers but at the expense of long migration times and high currents (above 100 μA). Addition 
of 20 mM 15-crown-5 to the Tris buffer, pH 8.0, containing 15 mg/mL sulfated β-CD significantly 
increased KIFM(O)K diastereomer separation (RS = 4.2). Because migration times of more than 20 
min were observed under these conditions, further method optimization was performed using 
experimental design in order to achieve sufficient peak resolution with short analysis times. 
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4.3.2 Method optimization by experimental design 
In order to identify the significant variables contributing to the separation, a fractional factorial 
response IV design (26-2 corner experiments, 3 replicates of the center point) was selected based on 
the preliminary experiments. Buffer pH (6.50 - 8.50), the concentrations of Tris (30 - 80 mM), 
sulfated β-CD (3 - 16 mg/mL) and 15-crown-5 (2 - 10 mM) as well as the applied voltage (22 - 27 
kV) and capillary temperature (18 - 24 °C) were evaluated. Peak resolution between KIFMK and 
KIFM-R-(O)-K and between KIFM-R-(O)-K and KIFM-S-(O)-K as well as migration time were 
selected as responses. The matrix of the design and the data obtained for the responses are 
summarized in Table 6. The data were fitted to the model using the partial least squares method. As 
it can be seen in Fig. 23, buffer pH, concentration of sulfated β-CD and capillary temperature were 
identified as significant variables which were further optimized. The rest factors were identified as 




Fig. 23: Regression coefficients plot of screening design of (A) peak resolution between KIFM-R-
(O)K and KIFM-S-(O)K and (B) migration time of KIFM-R-(O)K. The error bars represent 


































N=19         R2=0.908     R2 Adj.=0.861 





































N=19         R2=0.774     R2 Adj.=0.662 






Table 6. Matrix of the three level resolution IV fractional factorial design used for factor screening and experimental responses peak resolution, R, and migration        
               time, t. The index numbers refer to the peptide sequences: 1, KIFMK; 2, KIFM-R-(O)-K; 3, KIFM-S-(O)K. 
 










[°C] R1,2 R2,3 t1  [min] t2  [min] t3 [min] 
1 1 6.5 30 3 2 22 18 4.71 3.9 21.95 22.51 22.93 
2 10 8.5 30 3 2 27 18 1.3 0.2 6.31 6.5 6.51 
3 5 6.5 80 3 2 27 24 3.82 3.33 7.91 8.5 8.81 
4 6 8.5 80 3 2 22 24 1.1 0 7.3 7.5 7.5 
5 18 6.5 30 16 2 27 24 5.12 4.51 13.62 14.51 15.22 
6 19 8.5 30 16 2 22 24 2.31 1.83 8.04 8.33 8.51 
7 7 6.5 80 16 2 22 18 6.6 5.6 35.23 39.53 42.4 
8 16 8.5 80 16 2 27 18 3.32 2.9 9.29 9.53 9.69 
9 9 6.5 30 3 10 22 24 3.8 3.1 13.15 13.8 14.3 
10 15 8.5 30 3 10 27 24 1.41 0.35 5.74 5.92 5.97 
11 4 6.5 80 3 10 27 18 4.76 4.01 12.87 13.33 13.54 
12 14 8.5 80 3 10 22 18 2.93 2.3 11.21 11.5 11.72 
13 11 6.5 30 16 10 27 18 6.4 5.7 34.11 35.8 38.32 
14 8 8.5 30 16 10 22 18 4.6 4 10.41 11.2 12.3 
15 13 6.5 80 16 10 22 24 6.11 5.1 27.21 30.82 32.99 
16 3 8.5 80 16 10 27 24 4.11 3.52 7.77 8.23 8.52 
17 12 7.5 55 9.5 6 24.5 21 4.99 4.1 10.89 11.4 11.88 
18 17 7.5 55 9.5 6 24.5 21 4.66 3.9 10.27 10.9 11.26 
19 2 7.5 55 9.5 6 24.5 21 4.93 4.4 11.11 11.74 12.54 
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Subsequently, a five-level circumscribed central composite design was used to further optimize the 
significant variables buffer pH (7.6 - 8.4), sulfated β-CD concentration (5 – 15 mg/mL) and capillary 
temperature (18 – 22 °C), while the insignificant variables were fixed at the medium value of the 
previously investigated range. The pH range was narrowed compared to the factorial design because 
severe broadening of the peak of KIFMK was observed below pH 7.5 
Again, peak resolution between KIFMK and KIFM-R-(O)-K and between KIFM-R-(O)-K and 
KIFM-S-(O)-K as well as migration time served as the responses. The design matrix and the 
experimental results are summarized in Table 7. The effect of each of the factors as well as their 
interactions on the resolution of the diastereomers of KIFM(O)K and the migration time of KIFM-R-
(O)-K are shown in Fig. 24. The presence of significant square indicated the existence of quadratic 
behavior and non-linear effects. All R2 values were higher than 0.95 for the two responses and the 
Q2 values of the responses resolution and migration time were 0.88 and 0.62, respectively. This 
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N=17         R2=0.977     R2 Adj.=0.948 
DF=7         Q2=0.877     RSD=0.1958   Conf. lev.=0.95 



























































N=17         R2=0.950     R2 Adj.=0.886 
DF=7         Q2=0.622     RSD=0.5870   Conf. lev.=0.95 
(A) 
Fig. 24: Regression coefficients plot of response surface design of (A) peak resolution between KIFM-
R-(O) and KIFM-S-(OK and (B) migration time of KIFM-R-(O)K. The error bars represent 






Table 7. Response surface design matrix of the five level circumscribed central composite design used for method optimization and experimental responses peak   
               resolution, R, and migration time, t. The index numbers refer to the peptide sequences: 1, KIFMK; 2, KIFM-R-(O)-K; 3, KIFM-S-(O)-K. 
 
Exp. No. Run order pH Sulf. β-CD [mg/mL] Temp. [°C] R1,2 R2,3 t1 [min] t2 [min] t3 [min] 
1 5 7.6 5 18 3.83 3.3 10.89 11.38 11.68 
2 7 8.4 5 18 2.25 1.76 8.12 8.32 8.42 
3 15 7.6 15 18 6.16 4 11.95 12.51 12.85 
4 8 8.4 15 18 4.47 2.7 9.22 9.51 9.68 
5 17 7.6 5 22 3.32 2.97 8.98 9.33 9.54 
6 2 8.4 5 22 2.37 1.62 7.73 7.91 8.02 
7 13 7.6 15 22 5.15 3.65 9.95 10.35 10.6 
8 3 8.4 15 22 4.65 2.67 8.33 8.58 8.73 
9 1 7.33 10 20 5.85 4.76 13.55 14.33 14.83 
10 9 8.67 10 20 3.83 2 7.7 7.9 8.02 
11 6 8 1.6 20 2.03 1.61 7.57 7.79 7.95 
12 4 8 18.4 20 5.36 3.11 9.25 9.58 9.76 
13 11 8 10 16.6 3.75 3.14 10.78 11.2 11.43 
14 14 8 10 23.4 3.92 2.9 9.28 9.61 9.8 
15 12 8 10 20 4.15 3.23 9.77 10.19 10.31 
16 16 8 10 20 4.23 3.43 9.94 10.32 10.52 
17 10 8 10 20 4.45 3.71 9.98 10.37 10.58 
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Buffer pH and the concentration of sulfated β-CD displayed a significant influence on peak 
resolution while the migration time was mostly determined by buffer pH. Increasing the buffer pH 
led to a decrease of peak resolution as well as migration time while increasing the concentration of 
sulfated β-CD resulted in a significant increase of peak resolution and a concomitant increase of 
migration time. The temperature primarily influenced migration time. The response surface plots of 
the resolution of the most critical peaks KIFM-R-(O)-K and KIFM-S-(O)-K and the migration time 














The optimum of the experimental parameters with a high resolution and short migration times were  
Fig. 25: Response surface plots for (A) the resolution between KIFM-R-(O)K and  KIFM-S-(O)K and (B) 







The optimum of the experimental parameters with a high resolution and short migration times were 
predicted at a buffer pH of 7.85, a sulfated β-CD concentration of 14.3 mg/mL and a capillary 
temperature of 21.5 °C in combination with the previously fixed parameters of a 50 mM Tris buffer 
containing 5 mM 15-crown-5 and an applied voltage of 25 kV. RS = 3.63 for the KIFM(O)K 
diastereomers and a migration time of KIFM-R-(O)-K of 10.3 min were predicted. An 
electropherogram using the selected experimental conditions is shown in Fig. 26. The experimentally 
determined RS values of 3.14 ± 0.41 (n = 10) for the KIFM(O)K diastereomers and a migration time 










4.3.3 Method validation 
The optimized method was validated according to ICH guideline Q2(R1) [153] with regard to range, 
linearity, accuracy, LOD, LOQ and precision. The ratio of corrected peak areas of the analytes and 




Fig. 26: Electropherogram of a standard sample containing 160 μM KIFM(O)K, 40 μM KIFMK and 70 
μM Fmoc-β-Ala. Experimental conditions: 43/53.2 cm, 50 μm I.D. fused silica capillary, 50 mM 
Tris buffer, pH 7.85, containing 14.3 mg/mL sulfated β-CD and 5 mM 15-crown-5, 25 kV, 21.5 °C, 
detection at 214 nm. Peaks: 1, KIFM-S-(O)K; 2, KIFM-R-(O)K; 3 Fmoc-β-Ala,; 4 KIFMK,.  
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Table 8. Assay validation data using KIFM(O)K as substrate. 
Parameter KIFMK KIFM-R-(O)K KIFM-S-(O)K 
Range [μM] 15 - 220 10 - 220 10 - 220 
Linear equation y = 0.0099x - 0.0915 y = 0.0095x - 0.0061 y = 0.0093x - 0.0073 
Coefficient of determination, r2 0.9945 0.9976 0.9987 
Standard deviation of the slope 0.0004 0.0003 0.0002 
Standard deviation of the intercept 0.0128 0.0099 0.0077 
LOD / LOQ [μM] 4.3 / 15 3.4 / 10 2.8 / 10 
Repeatability (n=6)    
 Migration time (RSD) [%] 0.71 0.75 0.76 
 Corrected peak area (RSD) [%] 4.5 3.6 3.9 
Interday precision (n=3)    
 Migration time (RSD) [%] 1.8 2.9 3.6 
 Corrected peak area (RSD [%]) 5.2 3.8 4.6 
Accuracy (mean ± SD, n=3) 95.6 ± 5.2 103.6 ± 5.7 104.9 ± 3.3 
 
Eight equally spaced concentrations of KIFMK and KIFM(O)K (each analyzed in triplicate) were 
used for the construction of the calibration curve. The LODs and LOQs were calculated from the 
standard deviation of the y-intercepts, σ and the slope of the calibration curve, according to LOD = 
3.3σ/Slope and LOQ = 10σ/Slope. Intra- and interday precision were estimated by injection of a 
standard sample containing 160 μM KIFM(O)K, 80 μM KIFMK and 70 μM internal standard six 
times a day and three times on three consecutive days, respectively. Accuracy was estimated using 
also these concentrations by comparison of analyte samples prepared in enzyme matrix without the 
addition of DTT and immediately frozen at −80 °C with samples prepared in Tris buffer, pH 8.0, 
without the addition of enzyme or DTT.  
 
4.3.4 Enzyme incubations 
The method was applied to evaluate the stereospecificity of the recombinant human Msr enzymes, 
hMsrA and hMsrB2. 160 μM KIFM(O)K was incubated in Tris buffer, pH 8.0, containing 20 mM 
DTT, in the presence of 15 μg/mL hMsrA or hMsrB2 for 10 min. Control samples were obtained in 
the absence of enzyme. Fig. 27A shows electropherograms of incubations of KIFM(O)K in the 
presence of hMsrB2 (trace d) and hMsrA (trace c), respectively, indicating the stereospecificity of 
the sulfoxide reduction by the enzymes. No reduction of the substrate was observed in the absence of 
enzyme (trace b) and no interference was observed from matrix components (trace a) obtained from 




incubation of 160 μM KIFM(O)K with 1 μg/mL hMsrA is shown in Fig. 27B. KIFM-S-(O)-K 













Finally, the Michaelis-Menten kinetics were determined. Figure 28 shows the dependence of the 
initial velocity of the sulfoxide reduction by hMsrA or hMsrB2, as a function of the substrate 
concentration between 20 and 200 μM, corresponding to incubations with the substrate diastereomer 
mixture in the range 40 - 400 μM. The kinetic data were calculated from the increase of the KIFMK 








Fig. 27: (A) Electropherograms of Msr stereospeficicity, (a) a blank sample in the absence of analytes and 
(b) a control sample in the absence of enzyme, (c) hMsrA and (d) hMsrB2. 160 μM KIFM(O)K 
was incubated in the presence of 15 μg/mL hMsrA or hMsrB2 for 10 min. (B) Electropherograms 
of the time-dependent reduction of KIFM-S-(O)K by hMsrA. (B) 160 μM KIFM(O)K was 
incubated in the presence of 1 μg/mL hMsrA. Peaks: 1, KIFM-S-(O)K; 2, KIFM-R-(O)K; 3, 































































Table 9. Kinetic data of Msrs using KIFM(O)K as substrate. 
  hMsrA hMsrB2 
Km [μM] 135.6 ± 25.6 100.5 ± 19.8 
vmax [μM · min-1] 13.3 ± 1.3 9.3 ± 0.9 
kcat [min-1] 331.8 ± 32.5 21.3 ± 2.1 









Fig. 28: Initial velocity, v0, as a function of substrate concentration for (a) hMsrA and (b) hMsrB2 











































4.4 Off-line assay for recombinant fungal MsrA and mutants using synthetic peptide 
substrates 
A previous study has shown that peptide substrates with positively charged amino acid residues next 
to Met(O) are preferentially reduced by both human and fungal recombinant MsrA [42]. MsrA 
contains two highly conserved negatively charged amino acids (Asp 134 and Glu 99) in the active 
site which may contribute to the observed low conversion rates of peptide substrates with negatively 
charged amino acids flanking Met(O) [42]. To further confirm the findings, four N-acetylated and C-
terminally Dnp labeled peptide substrates KDM(O)DK, KDM(O)NK, KNM(O)DK and KFM(O)KK 
were selected for the evaluation the activity of fungal MsrA and the mutants EQ, DN and DE. 
The sequence KDM(O)DK was applied as the substrate possesses two negatively charged amino 
acids flanking Met(O), while the sequence KFM(O)KK was used as the substrate with one positively 
charged and one neutral amino acid flanking Met(O). The peptide KDM(O)NK and KNM(O)DK 
were applied as the substrates carry one neutral amino acid and one negatively charged amino acid 
flanking Met(O), but the positions for the amino acid residues were reversed. The mutant 
information refers to Table 1 in the chapter 3.1. The wild-type MsrA carries Glu99 (E) and Asp134 
(D) and was termed as ED. For the mutant EQ, the acidic Glu 99 in wild-type was replaced by Gln. 
In the cases of DN and DE mutant, Asp 134 was substituted by Asn and Glu, respectively. 
 
4.4.1 Separation of Met(O) peptide substrates 
A 50/60.2 cm, 50 μm id, fused silica capillary was applied for the separation of Met(O) peptide 
diastereomers. To ensure a quantitative assay, Fmoc-Ala was applied as the internal standard for all 
analytes. The separation of KDM(O)DK diastereomers was achieved using a 50 mM Tris-HCl, pH 
8.0, containing 15 mM SDS and 15 mg/mL sulfated β-CD. The diastereomers of KFM(O)KK was 
separated using a 50 mM Tris-HCl buffer with addition of 10 mg/mL sulfated β-CD at pH 7.5. 
Although the baseline diastereomer separation of KDM(O)NK and KNM(O)DK were achieved using 
50 mM Tris-HCl, pH 8.0, containing 10 mg/mL sulfated β-CD and 10 mM Kryptofix® 22, long 
migration times (over 30 min) was observed for the internal standard. As a compromise between 
peak resolution and analysis time, the separations of diastereomers of KDM(O)NK and KNM(O)DK 
were conducted with 50 mM Tris-HCl, pH 7.0, containing 12 mg/mL sulfated β-CD. Under these 
conditions, the diastereomers of KDM(O)NK and KNM(O)DK were separated in 15 min, with a 
resolution of 1.25 and 1.36, respectively. The methods were not further optimized.  
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4.4.2 Method validation 
The methods were validated according to ICH guideline Q2(R1) [153] with regard to range, linearity, 
accuracy, LOD, LOQ and precision. The ratio of corrected peak areas of the analytes and the internal 
standard (Fmoc-β-Ala) were used for quantitation. The validation data for the (S)-configured peptide 
diastereomer are summarized in Table 10. Because the method allows the separation of the 
diastereomers of the substrates, the validation data of the (R)-configured sulfoxide diastereomer 
could also be obtained but were not calculated.   
 
Table 10. Assay validation data using a group of Met(O)-containing peptides as substrates. 
 KDM-S-(O)DK KFM-S-(O)KK KDM-S-(O)NK KNM-S-(O)DK 
Range(μM) 16.7-184.0 17.2-190.0 15.3-174.6 16.5-182.0 
Slope/Intercept 0.0077/-0.0187 0.0063/0.0370 0.0068/-0.0079 0.0073/0.0218 
r2 0.9990 0.9977 0.9980 0.9989 
LOD/LOQ (μM) 5.6/16.7 5.7/17.2 5.1/15.3 5.5/16.5 
Repeatability (n=6) 
     Migration time     
(RSD) [%] 2.1 1.7 1.7 1.9 
 Corrected peak area 
(RSD) [%] 4.3 2.8 4.2 4.7 
Interday precision 
(n=3) 
     Migration time  
(RSD) [%] 3.9 3.3 4.0 3.8 
 Corrected peak area 
(RSD [%]) 4.5 3.9 5.4 5.1 
Accuracy (mean ± SD, 
n=3) 91.5 ± 6.5 93.5 ± 6.1 105.5 ± 9.4 90.7 ± 8.8 
 
Seven equally spaced concentrations of the respective Met(O) peptide (each analyzed in triplicate) in 
the range of 30-300 μM were used for the construction of the calibration curve. The concentration of 
the individual diastereomer was calculated from the ratio of both diastereomers. Intra- and interday 
precision were estimated by injection of a concentration 200 μM of the Met(O) peptide containing 60 
μM internal standard six times a day and three times on three consecutive days, respectively. 
Accuracy was estimated using also these concentrations by comparison of analyte samples prepared 
in enzyme matrix without the addition of DTT and immediately frozen at −80 °C with samples 




4.4.3 Enzyme incubations 
The incubations were conducted in Tris buffer, pH 8.0, in the presence of 20 mM DTT at 37 °C for 
15 min. Three enzyme concentrations, i.e., 5 μg/mL, 10 μg/mL and 15 μg/mL, were applied and each 
concentration was analyzed in triplicate. Control samples were prepared without the addition of 
enzyme. Fig. 29 shows representative electropherograms of incubations of the substrates in the 
presence of wild-type of MsrA. No reduction of the substrate was observed in the control samples 
and no interference was observed from matrix components obtained from an enzyme solution 

















Fig. 29: Electropherograms of incubations. 180 μM Met(O) peptide was incubated in the presence of wild-
type MsrA for 15 min at 37 °C. (A) Incubation of KFM(O)KK with 5 μg/mL enzyme. (B) 
Incubation of KDM(O)DK with 15 μg/mL enzyme. (C) Incubation of KNM(O)DK with 10 μg/mL 
enzyme. (D) Incubation of KDM(O)NK with 15 μg/mL enzyme. Peaks: 1, Met-S-(O)-containing 
peptide diastereomer; 2 Met-R-(O)-containing peptide diastereomer; 3, Fmoc-β-Ala; 4,Met-
containing peptide; Experimental conditions:(A) 50 mM Tris-HCl, pH 8.0, containing 15 mg/ml 
sulfated β-CD, 15 mM SDS, 25 kV; (B) 50 mM Tris-HCl, pH 7.5, 10 mg/mL sulfated β-CD, 25 
kV; (C) and (D), 50 mM Tris-HCl, pH 7.0, containing 12 mg/ml sulfated β-CD, 20 kV. Other 
conditions: 50/60.2 cm, 50 μm id, fused silica capillary, 20 °C, detection at 214 nm. 
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Fig. 30 summarizes the performance of the MsrA mutants compared to the wild-type enzyme of 
three enzyme concentrations for the four Met(O) peptide substrates. The decrease of Met-S-(O) 
diastereomer was followed for the activity determination. The values were calculated according to: 
                     
                                                       (6)                                                                                             
 
where Rcontrol and RMsrA represent the corrected peak area ratio of a control sample and a sample 
incubated with MsrA, respectively.  
At all concentrations of the wild-type enzyme and mutants essentially identical results were obtained. 
As it can be seen, KFM(O)KK which carries one positively charged amino acid flanking Met(O) 
appears to be the best substrates for fungal wild-type MsrA as well as the mutants, while 
KDM(O)DK with two negatively charged aspartic acid residues is the poorest substrate. Literature 
data also suggest that peptide substrates with amino acids like Asp or Pro adjacent to Met(O) cannot 
be efficiently reduced by MsrA enzymes [72]. Wild-type MsrA (Glu99, Asp134) showed the highest 
activity compared to the mutants towards all tested substrates. Furthermore, the mutant EQ (Gln99, 
Asp134) was the mutant with lowest activity towards all peptides with the exception of the substrate 
KNM(O)DK, while the mutant DN (Glu99, Asn134) displayed higher activity towards KDM(O)NK 
than KNM(O)DK. The mutant DE (Glu99, Glu134) was more active than other mutants for all the 
tested peptide substrates. These findings were generally in agreement with the previously reported 
results except that the reduction of KDM(O)DK by mutant DE (Glu99, Glu134) was not obeserved 































4.4.4 Molecular modeling  
In order to rationalize the various activity of the wild-type enzyme and the mutants toward the 
substrates, modelling was performed by the group of Prof. W. Sippl (University of Halle, Germany). 




































Fig. 30: Reduction of Met-S-(O) peptide diastereomer by fungal MsrA wild-type as well as mutated 
enzymes. 180 μM of each synthetic peptide containing Met(O) was subjected reduction by fungal 
MsrA (wt) or the mutated in the presence of 20 mM DTT and 50 mM Tris (pH 8.0) for 15 min at 
37 °C, with three enzyme concentrations, (A) 5 μg/ml, (B) 10μg/ml and (C) 15 μg/ml. ●, 
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with a substrate [Ac-Met-S-(O)-NHMe] (PDB ID 3bqf). This template shares a 43 % sequence 
identity with the fungal (A. nidulans) wild-type MsrA. 
The active site was defined by 6 Å around the substrate in the binding site [Ac-Met-S-(O)-NHMe]. 
Two types of constraints were set to bias the results towards undergoing the crucial expected 
interactions. A scaffold constraint was set so that the Met-S-(O) moiety of the peptides are able to 
adapt a similar position shown in the model (see Fig. 31A green). The other was an H-bond 
constraint with the side chain of E134 for the docking of the mutant DE, as found between the 











Although the docking was successful in placing the Met-S-(O) residue in its predicted position, it 
was difficult to draw a reasonable conclusion for the substrate preference of the Msr enzymes. The 
main reason was that the peptide obviously interacted at the surface of the enzyme. Since there are 
no pronounced binding pockets for the tested peptides, all the residues [except for Met-S-(O)] can 
only interact on the surface of the protein, some even projected into the solvent (data not shown). In 
the case of KKM(O)KK, the lysine residues can undergo many interactions with acidic/polar surface 
groups of the enzyme in which H-bond interactions can be observed between the lysine 
[KKM(O)KK, red] and the backbone of Pro133, the lysine [KKM(O)KK, red] and the backbone of 
Val135 and the lysine[KKM(O)KK, red] with the side chain of T186 (Fig. 31B).  
(A) (B) 
Fig. 31: Generated model of A. nidulans MsrA with substrate in binding site. (A) Ac-Met-S-(O)-NHMe and 
(B) Ac-KKM(O)KK-Dnp. Substrate is colored in green and Msr in orange. H-bond interactions 





Nonetheless, the model showed that Glu99 in the active site pocket was buried in the Met-S-(O) 
binding groove, which might contribute to the right placing of Met-S-(O) and, consequently, to the 
catalytic activity of Msr. Replacement of Glu99 (wild-type) by Gln (EQ mutant) resulting in loss of 
enzyme activity supported this hypothesis. Glu134 showed according to the model only H-bond 
interactions with the backbone of Met-S-(O), and there was no indication that it might also interact 
with flanking residues from the peptides. No improvement of the enzyme activity was observed 
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4.5 CE separation of Met(O)-containing pentapeptide diastereomers 
Although the successful separation of aryl and alkyl sulfoxide enantiomers as well as the sulfoxide 
enantiomers of the drugs has been accomplished [166-168], the separation of peptide diastereomers 
containing Met(O) has not been reported expect for the separation of KIFM(O)K described in 
chapter 4.3. Therefore, the aim of the present study was to further evaluate the separation method for 
Met(O)-containing pentapeptide diastereomers.   
 
4.5.1 Investigation of dual system of cyclodextrin and achiral crown ether  
In chapter 4.3, the diastereomers of KIFM(O)K were resolved by the use of a dual selector system 
composed of sulfated β-CD and 15-crown-5. In the present part, the dual selector system composed 
CDs and crown ethers was further investigated.  
 
4.5.1.1 Screening of CDs for diastereomer separation  
Evaluation of the separation conditions was performed using the N-acetylated and C-terminally Dnp 
labeled pentapeptides KDM(O)DK, KNM(O)DK, KVM(O)VK, KEM(O)KK and KIFM(O)K. 
Peptide pI values were calculated using the Gen-Script Peptide Property Calculator 
(www.genscript.com/sslbin/site2/peptide_calculation.cgi). Assuming that the oxidation of Met does 
not affect the isoelectric point (pI) of peptides, KDM(O)DK can be considered a neutral peptide with 
a pI of about 7.0. A pI value of 8.9 was calculated for KNM(O)DK, while the values of the 
remaining peptides were 10.5 [KEM(O)KK] and 10.8 [KVM(O)VK and KIFM(O)K]. Thus, all 
peptides are positively charged in the acidic pH range and, except for KDM(O)DK, also in the slight 
alkaline pH range. Therefore, the separation was investigated in a 40/50.2 cm, 50 μm id, fused-silica 
capillary in the pH range 2.5-9.5 using 50 mM Tris-citric acid buffers or phosphate-based buffers. 
However, no separation of the peptide diastereomers was observed under these conditions. 
Subsequently, neutral and charged CDs including native β-CD, methyl-β-CD, 2-hydroxypropyl-β-
CD, heptakis(2,6-di-O-methyl)-β-CD, sulfopropyl-β-CD, sulfobutylether-β-CD, sulfated γ-CD , 
sulfated β-CD, carboxymethyl-β-CD (CM-β-CD) and CM-β-CD were evaluated as buffer additives 
at a concentration of 15 mg/mL in a 50 mM Tris-HCl buffer at pH 2.5 and pH 8.0. At pH 2.5, only a 




β-CD. None of the analytes could be detected within 100 min under normal polarity of the separation 
voltage in the presence of sulfated β-CD even when reducing the concentration of the selector to 2 
mg/mL. Consequently, the concentration of sulfated β-CD was raised to 30 mg/mL and the polarity 
of the separation voltage was reversed. Under these conditions, KDM(O)DK and KNM(O)DK could 
be detected within 10 min but no diastereomer separation was observed. At pH 8.0, partial separation 
of the diastereomers of KIFM(O)K, KEM(O)KK, KDM(O)DK and KNM(O)DK was noted in the 
presence of 15 mg/mL sulfated β-CD with normal polarity of the separation voltage. Baseline 
separation (Rs > 1.5) of KIFM(O)K and KEM(O)KK was achieved in a BGE containing 20 mg/mL 
sulfated β-CD 50 mM Tris-citric acid buffer, pH 7.5. The other peptide diastereomers could not be 
baseline resolved no matter what sulfated β-CD concentration or buffer pH was investigated. All 
other investigated CDs proved to be ineffective as BGE additives for achieving at least a partial 
separation under the experimental screening conditions.  
 
4.5.1.2 Screening of the dual system of CDs and achiral crown ethers 
It has been reported in the literature that the addition of achiral crown ethers can enhance 
enantioseparations of primary amines including amino acids. 18-crown-6 [121, 122, 169] or diaza-
crown ethers [124, 125] have been used in combination with native β-CD or neutral β-CD 
derivatives. Consequently, the crown ethers 18-crown-6 and 15-crown-5 as well as the diaza-crown 
ethers Kryptofix® 22 (4,13-diaza-18-crown-6) and Krpytofix® 21 (7,13-diaza-15-crown-5) were 
studied in combination with β-CD, CM-β-CD and sulfated β-CD using Tris-citric acid buffers with a 
pH of 2.5 and 8.0 as BGEs. The concentration of the CDs was set at 10 mg/mL, while 18-crown-6 
and 15-crown-5 were tested at a concentration of 15 mM and the nitrogen-containing Krpytofix® 
crown ethers at 8 mM. The results in comparison with the sole use of CDs as additives are 
summarized in Tables 11 (pH 2.5) and 12 (pH 8.0). 
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       Table 11. Screening of Met(O) peptide diastereomer separation at pH 2.5  
    np, no peak observed within100 min. 
     RS, peak resolution calculated by the 32 Karat™ Software according to RS = 2(t2-t1)/(w1+w2); t1 and t2 are the migration times, and w1 and w2 are the widths of the peaks at the   
     baseline. 
       a peak separation was too low to calculate RS value 
 
Peptide CD CD alone    CD + 18-crown-6 CD + 15-crown-5 CD + Kryptofix® 22 CD + Kryptofix® 21 
    t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS 
KDM(O)DK β-CD 4.92 / 4.92 0 5.14 / 5.14 0 4.78 / 4.78 0 Np - 6.55 / 6.55 0 
 
CM-β-CD 6.57 / 6.57 0 7.70 / 7.70 0 7.31 / 7.31 0 Np - 8.75 / 8.75 0 
 
sulf. β-CD np - np - Np - Np - np - 
KVM(O)VK β-CD 4.91 / 4.91 0 5.35 / 5.35 0 5.12 / 5.12 0 Np - 12.55 / 12.55 0 
 
CM-β-CD 8.68 / 8.72 0a 12.65 / 12.72 0.47 10.21 / 10.29 0.35 Np - 13.77 / 13.85 0.52 
 
sulf. β-CD np - np - Np - Np - np - 
KIFM(O)K β-CD 6.82 / 6.82 0 8.73 / 8.73 0 7.55 / 7.55 0 Np - 18.99 / 19.18 0.87 
 
CM-β-CD 6.90 / 6.90 0 8.31 / 8.37 0.55 7.87 / 7.91 0a Np - 18.35 / 18.43 0.79 
 
sulf.β-CD np - np - Np - Np - np - 
KEM(O)KK β-CD 7.12 / 7.12 0 7.83 / 7.83 0 7.63 / 7.63 0 Np - 13.44 / 13.44 0 
 
CM-β-CD 7.56 / 7.56 0 8.97 / 9.11 0.63 7.84 / 7.84 0 Np - 14.33 / 14.46 0.55 
 
sulf. β-CD np - np - Np - Np - np - 
KNM(O)DK β-CD 6.32 / 6.32 0 6.91 / 6.91 0 6.71 / 6.71 0 Np - 13.33 / 13.33 0 
 
CM-β-CD 7.71 / 7.71 0 8.21 / 8.33 0.58 8.91 / 8.91 0 Np - 15.38 / 15.55 0.5 




       Table 12. Screening of Met(O) peptide diastereomer separation at pH 8.0 
Peptide CD CD alone CD + 18-crown-6 CD + 15-crown-5 CD + Kryptofix® 22 CD + Kryptofix® 21 
    t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS 
KDM(O)DK β-CD 3.23 / 3.23 0 3.86 / 3.86 0 3.52 / 3.52 0 5.63 / 5.63 0 4.93 / 4.93 0 
 
CM-β-CD 4.55 / 4.55 0 4.99 / 4.99 0 4.81 / 4.81 0 7.84 / 7.84 0 6.65 / 6.65 0 
 
sulf. β-CD 4.67 / 4.67 0 5.72 / 5.75 0.55 4.63 / 4.69 0.51 7.76 / 7.76 0 6.96 / 6.96 0 
KVM(O)VK β-CD 3.53 / 3.53 0 4.02 / 4.02 0 3.85 / 3.85 0 4.64 / 4.64 0 4.21 / 4.21 0 
 
CM-β-CD 4.45 / 4.45 0 5.17 / 5.17 0 4.99 / 4.99 0 21.94 / 22.47 1.17 14.17 / 14.38 0.96 
 
sulf. β-CD 4.74 / 4.74 0 5.28 / 5.28 0 5.12 / 5.12 0 13.39/ 13.39 0 11.53 / 11.53 0 
KIFM(O)K β-CD 3.77 / 3.77 0 4.25 / 4.25 0 3.99 / 3.99 0 10.81 / 10.91 1.21 9.12 / 9.21 1.31 
 
CM-β-CD 3.89 / 3.89 0 4.66 / 4.66 0 4.32 / 4.32 0 15.45 / 15.74 1.57 11.25 / 11.55 1.29 
 
sulf.β-CD 8.05 / 8.14 1.34 13.37 / 13.83 2.52 12.63 / 12.95 2.39 29.30 / 30.88 5.73 27.32 / 28.44 5.14 
KEM(O)KK β-CD 3.88 / 3.88 0 4.45 / 4.45 0 4.11 / 4.11 0 10.73 / 10.73 0 8.79 / 8.79 0 
 
CM-β-CD 4.11 / 4.11 0 4.55 / 4.55 0 4.32 / 4.32 0 15.15 / 15.37 1.21 10.52 / 10.64 1.02 
 
sulf. β-CD 11.74 / 11.87 1.41 14.89 / 15.07 1.83 13.03 / 13.21 1.62 26.90 / 27.98 4.32 19.91 / 20.34 2.51 
KNM(O)DK β-CD 4.45 / 4.45 0 4.75 / 4.75 0 4.61 / 4.61 0 9.83 / 9.83 0 8.22 / 8.22 0 
 
CM-β-CD 5.09 / 5.09 0 6.82 / 6.82 0 6.34 / 6.34 0 12.37 / 12.46 0.61 11.11 / 11.22 0.52 
  sulf. β-CD 6.84 / 6.84 0.56 9.55 / 9.64 1.02 8.53 / 8.61 0.89 11.86 / 11.95 1.44 10.88 / 10.96 1.39 
     np, no peak observed within 100 min. 
     RS, peak resolution calculated by the 32 Karat™ Software according to RS = 2(t2-t1)/(w1+w2); t1 and t2 are the migration times, and w1 and w2 are the widths of their peaks at the         
     baseline. 
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It should be noted that addition of a crown ether (either regular crown ether or diaza-crown ether) to 
the BGE in the absence of a CD in concentrations up to 20 mM did not result in any separation. The 
neutral crown ethers, 18-crown-6 and 15-crown-5, displayed a synergistic effect on the diastereomer 
separation in combination with CM-β-CD at pH 2.5 and with sulfated β-CD at pH 8.0. Only partial 
separations were observed at pH 2.5, while baseline separations could be observed for KIFM(O)K 
and KEM(O)KK with sulfated β-CD and the crown ethers at pH 8.0. Migration times increased in 
the presence of the crown ethers compared to the sole presence of CDs indicating that a ternary 
complex may be formed between peptide diastereomers, CDs and crown ethers as derived for amine 
analytes [121, 170, 171]. No separation could be observed in combination with native β-CD even at 
concentrations of up to 25 mg/mL of the CD.  
The pKa values of diaza-crown ethers are about 9 [172] so that the compounds are protonated at the 
pH values studied. Interestingly, none of the analytes could be detected at pH 2.5 in the presence of 
Kryptofix® 22 in CDs-based BGEs under both, normal and reversed polarity of the separation 
voltage. In contrast, partial diastereomer separation of several peptides were observed for 
Kryptofix® 21-containing BGEs. It may be speculated that the protonated Kryptofix® 22 is adsorbed 
to the capillary wall, thus, modifying the EOF while this occurs to a lesser extend in case of the 
smaller Kryptofix® 21 crown ether. Migration times increased as compared to the presence of the 
neutral crown ethers despite the fact that the charge of the complexes should be higher in the case of 
the protonated diaza-crown ethers. This further indicates that the diaza-crown ethers induced an EOF 
directed towards the anode. Finally, the diastereomers of KIFM(O)K were resolved by the 
combination Kraptofix® 21 and β-CD at pH 2.5. 
A significant synergistic effect between the CDs and the diaza-crown ethers was noted at pH 8.0. 
Except for KDM(O)DK with the approximate pI of 7.0, all other peptide diastereomers were at least 
partially separated using CM-β-CD. Effective separations were found in the presence of sulfated β-
CD with baseline resolution RS > 5 for KIFM(O)K in the presence of both diaza-crown ethers. The 
diastereomers of this peptide were even resolved when β-CD was used as CD component. Fig. 32 
illustrates the effect of the crown ethers on the diastereomer separation of KEM(O)KK under the 

















4.5.1.3 Effect of CD and crown ether concentration in the dual system 
The effect of different CD and crown ether concentrations on the separation of the peptide 
diastereomers was studied using 18-crown-6 and Kryptofix® 22 as well as sulfated β-CD, except for 
KVM(O)VK. In this case, CM-β-CD was applied because it proved to be an effective additive for the 
diastereomer separation of this peptide in the screening experiments. The experiments were 
conducted at pH 8.0 because efficient separations were observed at this pH in contrast to pH 2.5. The 
concentration of one type of selector was fixed while the concentration of the second selector was 
varied. The results are summarized in Fig. 33. 
Generally, with a few exceptions, an increase of peak resolution and migration time could be 
observed upon increasing the concentration of one selector while keeping the other selector constant. 
In the case of KNM(O)DK an optimum appears to exist for a CD concentration (with constant crown 
ether concentrations) of about 15 mg/mL because peak resolution decreased when further increasing 
the CD concentration (Fig. 33B and 33C). Only partial resolution of the diastereomers of 
KDM(O)DK was observed at concentrations of Kryptofix® 22 below 10 mM, while no separation 
was observed at higher concentration. 
 
 
Fig. 32: Effect of CDs and crown ethers as BGE additives on the separation of the diastereomers of 
KEM(O)KK. Experimental conditions: 40/50.2 cm, 50 μm id fused silica capillary, 50 mM Tris-
citric acid buffer, pH 8.0, 25 kV, 20 °C, detection at 214 nm. Buffer additives (A) 10 mg/mL 
sulfated β-CD, (B) 10 mg/mL sulfated β-CD and 15 mM 15-crown-5, (C) 10 mg/mL sulfated β-
CD and 15 mM 18-crown-6, (D) 10 mg/mL sulfated β-CD and 8 mM Kryptofix® 21, and (E) 10 
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  Fig. 33: Effect of the concentration of CDs and the crown ethers, 18-crown-6 and Kryptofix® 22, on (A-
D) resolution of Met(O) peptide diastereomers and (E-H) migration time of the first migrating 
diastereomer. Experimental conditions: 40/50.2 cm, 50 μm id fused silica capillary, 50 mM Tris-
citric acid buffer, pH 8.0, 25 kV, 20 °C, detection at 214 nm. CM-β-CD was used for the 
separation of KVM(O)VK while sulfated β-CD was used for the separation of the other peptides. 
The concentration of the CD was fixed at 10 mg/mL when varying the crown ether concentrations 
(A, C, E, G). The concentrations of 18-crown-6 was fixed at 15 mM (B, F) and Kryptofix® 22 at 8 
mM (D, H) when varying the CD concentration. ●, KDM(O)DK; ▲, KVM(O)VK; ○, 
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In contrast to the other systems, migration analyte times decreased in case of the Kryptofix® 22-
based BGE upon addition of 5 mg/mL of the CDs and subsequently increased at higher CD 
concentrations (Fig. 33H). This decrease did not correlate with a general decrease in peak resolution 
(Fig. 33D). It may be speculated that the positively charged diaza-crown ether is adsorbed to the 
capillary wall resulting in a slow EOF directed toward the anode. This can be counteracted by the 
presence of negatively charged CDs such as sulfated β-CD or CM-β-CD resulting in a faster 
migration of the positively charged analytes to the detector at the cathodic end of the capillary. The 
subsequent increase of the migration times at higher CD concentrations can be explained by the 
increased analyte complexation and increased viscosity of the buffer at higher CD concentrations. 
 
4.5.1.4 Effect of buffer pH 
The effect of the pH of the Tris-citric acid-based electrolyte was studied in a pH range 2.5 to 9.5 with 
BGEs containing 15 mg/mL CM-β-CD and 20 mM 18-crown-6 or 10 mM Kryptofix® 22. The diaza-
crown ether is only partially protonated above pH 9.0, while CM-β-CD will be protonated at pH < 3-
4. KVM(O)VK was used as model peptide because separations in CM-β-CD-based BGEs have been 
observed during the screening experiments. The peptide is positively charged over the entire pH 
range studied (pI of approximately 10.8). 
Fig. 34A shows the pH-dependent separation of the KVM(O)VK diastereomers using the 
combination of CM-β-CD and 18-crown-6 in Tris-Citric buffer. Increasing the pH of the BGE 
resulted in a deterioration of the diastereomer separation with a concomitant decrease of migration 
times. No separation could be observed at pH values above 4. This may be explained by the 
increased EOF at higher pH values leading to short migration times, which did not allow sufficient 
time for analyte-selector interactions.  
For the combination CM-β-CD and Kryptofix® 22, long migration times were observed at pH values 
below 6.5. The dependence of the resolution of the diastereomers of KVM(O)VK in the pH range 6.5 
– 9.5 is depicted in Fig. 34B. The highest resolution was found at pH 7.5 to 8. Further increase of the 
pH resulted in a loss of resolution. Migration times also significantly decreased, e.g. from about 45 
min at pH 7.5 to about 25 min at pH 8.5 with a concomitant decrease of resolution from 2.4 to 2.1. 
The effect of the change of the charge of the selectors as a function of buffer pH on the formation of 
the ternary complex with the positively charged peptide could not be concluded from the present 
data. 












4.5.2 Separation of Met(O)-containing peptide diastereomers by CD-mediated MEKC 
The dual system of CDs and achiral crown ethers showed a high ability for the separation Met(O)-
containing peptide diastereomers. However, only partial resolution of the diastereomers of 
KDM(O)DK (neutral peptide) was observed at concentrations of Kryptofix® 22 below 10 mM，and 
no separation was observed at higher concentrations (Chapter 4.5.1.3). The dual system proved to be 
ineffective for the further separation of the neutral Met(O) peptide diastereomers NM(O)N and 
KEM(O)EK. It may be speculated that crown ethers have only week interaction with neutral peptide 
diastereomers so that the critical “sandwich complex” contributing to the separation cannot be 
formed.  
As it has been reported, CD-mediated MEKC can be used alternatively for the separations of chiral 
compounds including peptide enantiomers [173 - 176]. Thus, CD-modified MEKC was investigated 
using a 50 μm id, 50/60.2 cm fused silica capillary. The diastereomers of KDM(O)DK and NM(O)N 
showed only low resolution at pH 6.5 and pH 8.0 with a 50 mM Tris buffer, containing 25 mM SDS. 
The separation was not able to be significantly improved by varying buffer pH and the 
concentrations of SDS. Only a very limited separation was observed for KDM(O)DK with 10 
mg/mL sulfated β-CD in 50 mM Tris-HCl buffer, at pH 8.0. The other two Met(O) peptide 
diastereomers showed no separation under this condition. Other CDs were not able to separate the 
tested peptide diastereomers. For the investigation of CD-mediated MEKC, sulfated β-CD was 
chosen based on the preliminary CD screening results. Native β-CD was also selected as a reference. 
Fig. 34: pH-Dependence of the separation of the KVM(O)VK diastereomers using (A), the combination of 
15 mg/mL CM-β-CD and 20 mM 18-crown-6 and (B), the combination of 15 mg/mL CM-β-CD and 
10 mM Kryptofix® 22. Experimental conditions: 40/50.2 cm, 50 μm id fused silica capillary, 50 mM 
































The concentration of the CDs was set at 10 mg/mL and SDS was applied at a concentration of 20 
mM. Because an unstable baseline and long migration times were observed at a buffer pH below 6.0, 
the screening pH was set at 6.5 and 8.0. It should be mentioned that all the tested peptides are 
generally neutral at pH 6.5 while KDM(O)DK and KEM(O)EK are slightly negatively charged at pH 
8.0. The screening results are summarized in Table 13 and Table 14. 
 
Table 13. Screening of Met(O) peptide diastereomer separation using CD-MEKC at pH 6.5 
Peptide CD CD alone SDS alone CD + SDS 
  
t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS 
NM(O)N β-CD 6.15 / 6.15 0 13.13 / 14.23 1.77 10.26 / 11.20 1.77 
 sulf. β-CD 8.54 / 8.54 0   18.33 / 20.16 2.82 
KDM(O)DK β-CD 7.00 / 7.00 0 22.63 / 23.93 1.35 18.59 / 20.00 1.29 
 sulf. β-CD 15.55 / 15.76 0.25   30.88 / 33.02 2.18 
KEM(O)EK β-CD 7.10 / 7.10 0 30.90 / 32.12 0.58 26.88 / 27.89 0.49 
 sulf. β-CD 11.23 / 11.23 1.34   40.78 / 43.12 1.58 
 
Table 14. Screening of Met(O) peptide diastereomer separation using CD-MEKC at pH 8.0 
Peptide CD CD alone SDS alone CD + SDS 
  
t1 / t2 [min] RS t1 / t2 [min] RS t1 / t2 [min] RS 
NM(O)N β-CD 4.20 / 4.20 0 7.00 / 7.18 1.00 6.12 / 6.26 0.98 
 sulf. β-CD 4.53 / 4.53 0   8.87 / 9.13 1.62 
KDM(O)DK β-CD 4.65 / 4.65 0 11.12 / 11.23 0.75 9.88 / 10.00 0.76 
 sulf. β-CD 6.23 / 6.26 0   12.91 / 13.33 1.45 
KEM(O)EK β-CD 5.14 / 5.14 0 10.52 / 10.53 0 8.88 / 8.88 0 
 sulf. β-CD 6.33 / 6.33 0   16.27 / 16.40 0.78 
 
Effective separations were observed using sulfated β-CD-mediated MEKC. At pH 6.5, baseline 
separations weres achieved for all peptide sequences but with relatively long analysis times. While at 
pH 8.0, the analysis time was significantly decreased, the resolution between the diastereomers 
deteriorated as well. This might be attributed to the high EOF generated at a high pH which led to 
insufficient time for the interactions between analyte and buffer additives. β-CD had little selectivity 
towards Met(O) peptide diastereomers, but the migration time was shorter in β-CD-mediated MEKC 
than using a MEKC method in the absent of β-CD . In the case of KDM(O)DK, the migration time 
was reduced from 11.12 min to 9.87 min with an addition of 10 mg/mL β-CD to 50 mM Tris-HCl 
buffer containing 20 mM SDS, pH 8.0, while the resolution of the diastereomers was unaffected. A 
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synergistic effect was observed for sulfated and SDS micelles. This is probably due to the fact that 
sulfated β-CD itself also displayed week recognition for Met(O) diastereomers. Fig. 35 illustrates the 













The study revealed that addition of sulfated β-CD for a SDS-containing BGE was effective for the 
separation of neutral Met(O) peptide diastereomers. Interestingly, using this system for the basic 
Met(O) peptide diastereomers resulted in little separation but long migration times (over 60 min). 
For example, for the separation of KIFM(O)K, no peak was detected within 60 min using a 50 mM 
Tris-HCl, pH 8.0, containing 10 mg/mL sulfated β-CD and 15 mM SDS. It may be speculated that 
the positively charged peptide was incorporated into the negatively charged micelles to a great extent 
by static interactions and, as a consequence, migrated with the SDS micelles towards the anode. 




(A) (B) (C) 
Fig. 35: Electropherograms of the separation of the diastereomers of KDM(O)DK. Experimental 
conditions:50/60.2 cm, 50 μm id fused silica capillary, 50 mM Tris-HCl buffer, pH 8.0, 25 kV, 
20 °C, detection at 214 nm. Buffer additives (A) 10 mg/mL sulfated β-CD, (B) 20 mM SDS, (C) 
10 mg/mL sulfated β-CD and 20 mM SDS. 
 

















































































5 Discussion  
Met residues in peptides and proteins are easily oxidized to Met(O). The latter exists as a pair of 
diastereomers, Met-S-(O) and Met-R-(O). Reduction of Met(O) diastereomers is catalyzed by Msrs 
in a stereospecific manner, i.e., MsrA reduces Met-S-(O) and MsrB reduces Met-R-(O). Separation 
of Met-S-(O) and Met-R-(O) is often challenging for the study of the stereospecificity of Msr 
enzymes. Therefore, the individual diastereomer dabsyl-Met-S-(O) and dabsyl-Met-R-(O) are most 
frequently used as substrates in reported stereospecific assays, [36, 73]. Since Met(O) residues are 
formed as a pair of diastereomers physiologically, the racemic mixture of Met(O) was chosen as the 
substrate for our study. In order to establish stereospecific CE methods that cover all kinds of 
substrates, three representative substrates were selected, which were free Met(O), Fmoc-Met(O) and 
Met(O)-containing pentapeptide. The separation of Met(O) diastereomers was achieved by different 
CE modes and will be discussed. Subsequently the separation methods were applied to enzyme 
assays. Both off-line and on-line CE assays were established. 
 
5.1 Separation of substrate diastereomers 
5.1.1 Separation of Met(O) derivatives by MEKC 
MEKC method was found very effective for the separation of Met(O) derivatives including dabsyl-
Met(O) and Fmoc-Met(O). In MEKC, the EOF is directed toward the cathode, while SDS micelles 
migrate to the anode. As a result, the overall micellar velocity is reduced counteracted by the bulk 
flow. The Met(O) diastereomers partition into and out of the micelles and, consequently, their 
migration velocities are affected by this equilibrium. The separation occurrs due to the difference of 
hydrophobic interactions between the diastereomers and the micelles.  
The method described by Uthus [99] employed an uncoated fused-silica capillary with a 25 mM 
KH2PO4 buffer, pH 8.0, containing N-laurylsarcosine as BGE. In addition, a buffer containing an 
additional 25 mM SDS in BGE was applied as conditioning solution, which was considered critical 
for the baseline separation of dabsyl-Met(O) diastereomers. Because SDS is incompatible with 
potassium ions and leads to the formation of a precipitate [156], KH2PO4 was replaced by NaH2PO4 
in the present assay. Using a 35 mM phosphate buffer, pH 8.0, containing 25 mM SDS resulted in 
baseline separation of dabsyl-Met(O) diastereomers. This indicated that the presence of N-




However, using this system a variation of the EOF and consequently shifting migration times of 
analytes were observed. Performing a dynamic coating by an addition of 0.04% (m/v) polyethylene 
oxide to the BGE improved precision of the migration times (RSD < 6%) but resulted in long 
analysis time (more than 30 min).  
In order to achieve a stable EOF and shorter analysis times, a SMIL-coated capillary was applied 
with polybrene as the cationic polymer and dextran sulfate as the anionic polymer. The illustration of 
coating procedure is shown in Fig. 36. The dextran sulfate coating provided a stable and strong 











The bi-layer was initially coated by rinsing the capillary with 5% (w/v) aqueous polybrene for 15 
min followed by the rinse of 3% (w/v) dextran sulfate solution for 30 min according to Katayama 
[151, 177]. The procedure was further optimized with an additional rinse of water between the 
coating reagents, in order to avoid that the two oppositely charged polyelectrolytes interact at the 
interface of the capillary [178, 179]. This optimization resulted in a more reproducible coating 
procedure. Application a voltage of 10 kV for 10 min led to a fast capillary condition for a new 
coated capillary.  
The coating efficiency might depend on the static interaction between silanol groups of the fused 
silica capillary and coating reagent. Katayama et al. further concluded from their study that the 
coating efficiency primarily depends on the interaction between the ionized silanol groups of the 
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inner capillary wall and polybrene while dextran sulfate completely covered the polybrene layer 
[151]. Furthermore, their study shows that capillaries from different sources lead to a variance of the 
velocity of the EOF in case of a single layer coating, while this variance deceased significantly after 
dextran sulfate covered on the polybrene layer due to strong interactions between polybrene and 
dextran sulfate [151]. Therefore, one may speculate that polybrene plays a critical role in the coating 
efficiency. Unfortunately, when switching from one batch of polybrene to another, a change in the 
magnitude of EOF was observed. Commercial polybrene is a poorly characterized chemical with 
regard to polymer size, and this may be the reason for the observed variations. Thus, changing the 
batch of polybrene in routine analysis of a validated method has to be considered with care. Using 
dextran sulfate obtained from different batches did not lead to significant changes in migration times, 
but a dependence of the EOF on the concentration of dextran sulfate coating solution was observed. 
It may be speculated that complete coverage of the polybrene layer by dextran sulfate is necessary 
when using MEKC conditions because SDS may also adsorb to the polybrene layer and further 
change the magnitude of the EOF. 
The MEKC method employing a SMIL-coated capillary was found very effective for the separation 
of Met(O) derivatives, i.e., dabsyl-Met(O) and Fmoc-Met(O) diastereomers. The separation could be 
conducted in a buffer with a broad pH range. In the separation of dabsyl-Met(O), using a 35 mM 
phosphate buffer containing 25 mM SDS, resolutions of the diastereomers were found between 2.1 – 
2.9 in the pH range 7.0 – 9.0, with migration times from 10.7 – 12.5 min. This might be attributed to 
the dextran sulfate coating which provided an independent EOF and, therefore, the separation was 
barely influenced by buffer pH.     
 
5.1.2 Separation of Met(O)-containing pentapeptide diastereomers  
A set of synthetic Met(O)-containing peptides was chosen from a previous study [42], which 
intended to investigate the impact of Met(O)-neighboring amino acids of substrate peptide on the 
Msr activity. To ensure solubility, lysine residues were incorporated at positions -2 and +2 for most 
peptides. KIFM(O)K was used in this assay as the standard substrate for enzymatic activity testing. 
All peptides were N-acetylated with C-terminal Dnp-labeled. Peptides are listed in Table 15 and can 












5.1.2.1 Dual cyclodextrin-achiral crown ether system 
Separation of Met(O) peptide diastereomers was not possible by MEKC with SDS as micelles. 
Therefore, alternative separation conditions were investigated. The use of the combination of β-CD 
and achiral crown ether was initially reported to separate enantiomers of primary amines including 
amino acids [121, 122, 124, 125]. The separation is assumed to be based on the formation of a 
sandwich-type complex between the analyte and the respective CD and crown ether [170, 171]. Fig. 
37 shows a possible sandwich complex mode for the separation of the primary amine compounds. It 
may be speculated that, the primary amino group which is protonated in the acidic buffer that enables 
the interaction with the crown ether, while the hydrophobic moiety of the molecule is incorporated 
into the cavity of the cyclodextrin. As a consequence, the transient diastereomeric complexes may 
become more distinguishable and, as a result, a separation is achieved when the binding constants for 
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Fig. 37: A sandwiched complex mode (achiral 18-crown-6+cyclodextrin) for separation of chiral 
primary amino compounds.  
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Interestingly, this dual system was found also effective for the separation of Met(O) peptide 
diastereomers even though the molecular size of a peptide is much larger than an amino acid. The 
positively charged moiety of the peptide may interact with the crown ether while the hydrophobic 
residue was incorporated into the CD cavity to form the sandwich complex. Molecular modeling 
studies have also suggested that the binding energy differences between enantiomers in the sandwich 
complex is the reason for the chiral separation of primary amines [169]. Modeling studies could 
rationalize the mechanism of the separation Met(O) peptide diastereomers using this dual system.  
It should be noted that the addition of a crown ether (either neutral crown ether or diaza-crown ether) 
to the BGE in the absence of a CD in concentrations up to 20 mM was not able to result in any 
separation. Thus, it is easy to speculate that the intermediate of the complex formed between a crown 
ether and the analyte with the CD is the most critical step for the diastereomer separation. Thus, the 
basic peptide diastereomers with high hydrophobicity such as KIFM(O)KK, KFM(O)FK, 
KVM(O)VK, KFM(O)KK and KKM(O)FK were separated effectively using this dual system. The 
synergistic effect between CD and crown ether was not observed for the separation of neutral 
Met(O)-containing peptide diastereomers. This is probably because the interaction between crown 
ether and neutral peptide is too week to form the sandwich complex for the separation.  
 
The effect of neutral crown ether 
The data presented in chapter 4.5.1.4 reflects that, the neutral crown ethers, 18-crown-6 and 15-
crown-5, displayed a strong synergistic effect on the diastereomer separation in combination with 
CM-β-CD at pH values < 4.0. Increasing the buffer pH resulted in a deterioration of the diastereomer 
separation with a concomitant decrease of migration times. This may be explained by the fact that, at 
low pH primary amino groups were completely pronated so that it be able to interact with neutral 
crown ethers to form host-guest complexes. The low EOF at low pH that allowed sufficient time for 
analyte-selector interactions was also beneficial for the separation. For the combination with sulfated 
β-CD, a slight improvement of the diastereomer separation was even observed at pH 8.0 when the 
analytes were only partially positively charged.   
 
The effect of diaza-crown ether 
In the case of diaza-crown ethers, more significant synergistic effect was observed in a broad pH 
range. For instance, in combination with sulfated β-CD, baseline separation of the KIFM(O)K 




pH range 7.0 - 10.0. The diastereomers of KIFM(O)K were even resolved by the combination of 
Kryptofix® 21 and native β-CD at pH 2.5. 
Interestingly, none of the analytes could be detected at pH 2.5 in the presence of Kryptofix® 22 under 
both, normal and reversed polarity of the separation voltage. A similar behavior has also been 
observed by Iványi and colleagues when they attempted the enantioseparation of Trp by the 
combination of Kryptofix® 22 and neutral CD derivatives [124]. In contrast, partial diastereomer 
separation of several peptides was observed for Kryptofix® 21. It may be speculated that the 
Kryptofix® 22 which is pronated below pH 9.0 is adsorbed to the capillary wall, thus, modifying the 
EOF while this occurs to a lesser extend in case of the smaller Kryptofix® 21 crown ether. Diaza-
crown ethers have been used for EOF modification and reversal for the separation of inorganic ions 
as bifunctional modifiers [180, 181]. The adsorption of Kryptofix® 22 can be counteracted by the 
presence of negatively charged CDs such as sulfated β-CD or CM-β-CD, resulting in a faster 
migration of the positively charged analytes to the detector at the cathodic end of the capillary. This 
explains that the migration times decreased in case of the Kryptofix® 22-based BGEs upon addition 
of 5 mg/mL of sulfated β-CD or CM-β-CD (see Fig. 33H). The subsequent increase of the migration 
times at higher CD concentrations can be explained by increased analyte complexation and increased 
viscosity of the buffer at higher CD concentrations. Migration times increased compared to the 
presence of the neutral crown ethers despite the fact that the charge of the complexes should be 
higher in the case of the protonated diaza-crown ethers. This further indicates that the diaza-crown 
ethers induced an EOF directed towards the anode. 
The combination of CM-β-CD and Kryptofix® 22 provided the highest resolution at pH 7.5 to 9.0 for 
the separation of the KVM(O)VK diastereomers. A further increase of the pH from 7.5 to 8.5 led to a 
decrease of resolution from 2.4 to 2.1 with a concomitant significant decrease of migration time from 
45 min to 25 min. Thus, the recommended pH for the separation would be 8.0 to 8.5 as a 
compromise between resolution and analysis time. One may assume that the decrease of the 
migration times (and loss of resolution) is due to the fact that Kryptofix® 22 is less protonated at pH 
8 - 8.5. In this case, the interaction of the crown ether with the capillary wall is weakened resulting in 
a change of the EOF directed towards the cathode. However, the synergistic effect was still observed 
















5.1.2.2 Cyclodextrin-mediated MEKC 
As a further separation study for the Met(O) peptide diastereomers, CD-mediated MRKC was 
employed. The combination of micelles and CD is often used when the sole system is ineffective 
[173 - 175]. The separation is considered to be based on the analyte distribution in the system 
consisting of the micelle, CD and aqueous buffer [182, 183].The equilibrium of a CD-mediated 
MEKC system is illustrated in Fig. 39. Micelles and CDs coexist in the aqueous buffer. Since CD 
has a hydrophilic outer surface, there is little driving force for micellar incorporation [183]. A 




























Fig. 39: Illustration of the equilibrium of a CD mediated-MEKC system.  
(A) (B)      
Fig. 38: Electropherograms of the diastereomer separation of KVM(O)VK. Experimental conditions: 
40/50.2 cm, 50 μm id fused silica capillary, 25 kV, 20 °C, detection at 214 nm.50 mM Tris-citric 
acid buffer, pH 9.5. Buffer additives (A) 15 mg/mL CM-β-CD, (B) 15 mg/mL CM-β-CD, 10 mM 
Kryptofix® 22.  
 




































In chapter 4.5.2, for the neutral β-CD-MEKC system, the peptide molecules that were included in the 
SDS micelles migrated towards anode, while the analyte complexed with β-CD migrated towards 
cathode. As a consequence, the migration times of the peptide diastereomers were reduced without 
loss of peak resolution between the diastereomers. Further increase of the concentration of β-CD 
may lead to a decrease of peak resolution. In case of using negatively charged CD-mediated MEKC, 
the addition of sulfated β-CD to SDS-based BGE resulted in an increase of resolution as well as 
migration times. This was because sulfated β-CD displayed slight recognition between the 
diastereomers which contributed to an improved peak resolution. The peptide incorporated by the 
negatively charged CD migrated to the anode, thus the analysis times was prolonged.  
The substitution of sulfated β-CD with sulfated γ-CD in CD-mediated MEKC resulted in a slight 
improvement of diastereomer separation. Fig. 40 shows electropherograms of the separation of 
KDM(O)DK by sulfated γ-CD-mediated MEKC. It seems that the large cavity of the γ-CD better 










All neutral peptide diastereomers were baseline or close to be baseline resolved using sulfated β-CD-
mediated MEKC. For the basic peptides, however, strong electrostatic interactions exist between the 
positively charged peptide and the negatively charged SDS micelles. As a result, they are 
preferentially incorporated into the micellar phase, which does not allow the separation principle of 
CD-mediated MEKC to be effectively realized.  
Fig 40: Electropherograms of diastereomer separation of KDM(O)DK. Buffer additives (A) 10 mg/mL 
sulfated γ-CD (B) 10 mg/mL sulfated γ-CD and 20 mM SDS and (C) 10 mg/mL 10 mg/mL sulfated 







   
   












(A) (C) (B) 


































5.2 Assays for Msr enzymes 
85 
 
5.2 Assays for Msr enzymes 
5.2.1 Off-line assay using free Met(O) as substrate 
The MEKC method allowed the baseline separation of dabsyl-Met(O) and dabsyl-Met and was 
successfully applied to the determination of the stereospecificity of hMsrA and fungal fRMsr 
enzymes toward Met(O) diastereomers as substrates. The method was highly repeatable with regard 
to migration time of the analytes. An internal standard ensured the repeatability of the assay. This 
method can be used for the screening of the stereospecificity of Met(O) reductases as well as for the 
determination of enzyme kinetic data. An advantage of thw assay is the fact that free Met(O) can be 
used as substrate. In contrast to commonly used coupled reactions involving Trx and Trx reductase, 
no additional enzymes are required. 
Enzyme kinetic data of human MsrA with Met(O) as substrate have not been published. However, 
Kwak et al. recently reported a Km value of 350 ± 60 μM for mouse MsrA toward free Met(O) as 
substrate [164], which is in the same order of magnitude as found for hMsrA in the present study. Km 
values in the range between 240 ± 30 μM and 2100 ± 200 μM and Kcat values in the range 0.30 ± 
0.03 to 7.71 ± 0.03 s-1 have been found for MsrA of microorganisms [163].  
 
5.2.2 Electrophoretically mediated microanalysis (EMMA) 
In on-line assays, the enzyme is either immobilized on the surface of the capillary wall or present in 
solution. Since the SDS in the MEKC BGE would impair the activity of Msr enzymes, the partial 
filling mode was selected using a bracket of incubation buffer in order to separate enzyme and 
substrate solution from the separation buffer. The efficient mixing of substrate and enzyme is an 
important issue. This can be achieved by diffusion during injection and/or incubation depending on 
the injection process. Longitudinal and transverse diffusion contribute to the mixing process [140, 
158, 159]. The second approach is based on the electrophoretic mobilities of substrate and/or enzyme 
so that mixing is achieved by application of a mixing voltage for a short period of time [126, 139, 
160]. The electrophoretically mediated mixing using the injection sequence “enzyme-substrate-
enzyme” showed the maximum sulfoxide reduction among all the tested mixing methods including 
diffusion. It can be concluded that electrophoretical mixing provided higher mixing efficiency than 
simple plug diffusion in the present assay. 
The duration of the application of the mixing voltage was evaluated at a 1 kV in case not to impair 




resulted in a decrease of resolution between the Fmoc-Met(O) diastereomers. More importantly, 
frequent breakdowns of the electric current were observed when separating at 37 °C due to 
generation of Joule heating. Therefore, a voltage of 25 kV was applied for 1 min in order to separate 
enzyme and substrate before cooling the capillary to 25 °C.   
Since the exact volume for an on-line incubation is unknown, the exact concentration of the enzyme 
working for the on-line reaction cannot be defined as well. Compared to the off-line assay, a higher 
amount of enzyme was applied to obtain comparable enzymatic reduction (20 μg/mL versus 5 
μg/mL). This could be mainly attributed to the incomplete overlap of the reactant plugs [187, 188]. 
Depending on the efficiency of plug mixing by diffusion and electrokinetic transport, the enzyme 
plug is assumed to be diluted as well.   
In order to monitor the performance of the EMMA method, the kinetic parameters of Msrs were 
determined and compared to the data obtained with off-line assay. As is shown in Table 5, 
essentially identical values were determined in both assays. With the on-line incubation, it is 
important to mention that quantities of the enzyme that contributed directly to the reaction is not 
exactly known, so that the Kcat values cannot be determined. Compared to the literature data, using 
comparable incubation conditions, i.e., Tris buffer, pH 8.0 and DTT as reducing agent, Km values in 
the low millimolar range (1.10 ± 0.12 to 2.12 ± 0.36 mM) were observed for MsrA enzymes from the 
Arabidopsis family [77] using Fmoc-Met(O) as substrate. The present data for human enzymes are 
about 10-fold lower, which can be explained by species differences. However, the data reported in 
the present study for Fmoc-Met(O) as substrate are in the same range as Km values reported for 
mammalian Msr enzymes in assays that employed dabsyl-Met(O) as substrate and DTT as reducing 
agents. A Km value of 51 ± 38 μM was described for MsrA [164], while values ranging between 15 ± 
6 μM and 1.3 ± 0.2 mM were observed for MsrB [164, 189]. This clearly demonstrates the 
usefulness of the EMMA assay for the determination of the stereospecific reduction of Met(O) by 
Msr enzymes. Furthermore, it is interesting to note that Fmoc-Met-R-(O) is a substrate for MsrB 
enzymes, which has not been reported before. Whether this is only true for mammalian enzymes or 
also applies to MsrB from other species will have to be elucidated in the future. It has been shown 
that Fmoc-Met(O) is a substrate for plant MsrA in Pisum sativum L., but neither the stereoselectivity 
nor enzyme kinetic date has been determined for this enzyme [76]. 
Compared to the off-line assay, the EMMA assay can be completed in a shorter period of time for 
screening the activity of Msr enzymes because no sample workup is required. Moreover, the assay is 
fully automated and requires smaller amounts of enzyme and substrates, which reduces the overall 
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cost of the assay. On the other hand, off-line assays are generally easier to establish because buffer 
compatibility between incubation buffer and separation buffer do not have to be considered.  
 
5.2.3 Off-line assays using Met(O)-containing pentapeptides as substrates 
Dabsyl-Met(O) has been frequently applied as the mimics of peptide substrates [163, 164]. However, 
Met(O) derivatives are not peptide so that they may not reflect the activity of Msr enzymes towards 
peptide-bound Met(O). Therefore, Met(O)-containing peptide substrate was applied. KIFM(O)K was 
used as the standard substrate for the activity test in the previous studies [42, 149, 165] so it was 
chosen in our assay. The separation of KIFM(O)K diastereomers as well as the reduced peptide 
KIFMK was optimized under the help of the design of experiment. The method was successfully 
applied for the enzyme assay. Table 16 shows the kinetic data obtained using KIFM(O)K as 
substrate as well as the data using free Met(O) and Fmoc-Met(O) as substrates, and the literature data 
with dabsyl-Met(O) or oxidized Met-rich proteins as substrates. It should be noted that for a Trx 
reduction system, the enzymatic activity refelcts the complete enzymatic system including Trx 
reductase and Msr [58, 163, 164, 190]. For a DTT system, using different concentrations of DTT can 
result in various enzyme activities [191]. Furthermore, the kinetic performance for a specific Msr 
from different species can differ as well [163]. 
The Km values observed for KIFM(O)K in our assay as well as reported data of protein substrates 
[84] for both enzymes in different organisms are lower compared to the data obtained from Met(O) 
derivatives, i.e., Fmoc-Met(O) and dabsyl-Met(O) [58, 164]. In contrast, the Kcat values of peptide 
and protein substrates are higher, which results in a significantly higher Kcat/Km quotient. It appears 
that peptide-bound and protein substrates are better substrates which can be efficiently reduced by 
both, MsrA and MsrB, compared to free Met(O) and its derivatives. Studies on the substrate 
specificity of MsrA and MsrB from N. Meningitidis [192 - 194] also support the idea that the active 
sites of both Msrs are rather adapted for binding protein-bound Met(O) more tightly than free 








 Table 16. Msr kinetic data obtained with the substrate KIFM(O)K compared to free Met(O), Fmoc-Met(O) as 




Substrate Reduction system 
Kcat Km Kcat/Km 
Ref. 
(S-1) (μm) (mM-1·min-1) 
MsrA        
Human  Free Met(O) DTT 5.5 ± 0.3 390 ± 47.3 840 Results 
Human 
 
Fmoc-Met(O) DTT 0.13 ± 0.01 256 ± 27.9 31 Results 
Human 
 
KIFM(O)K(a) DTT 5.5 ± 0.5 135.6 ± 25.6 2447 Results 
Mouse  dabsyl-Met(O) DTT 0.28 ± 0.02 340 ± 40 49 [58] 
E.coli 
 
MRP4 Trx 13.0 ± 5.4 137 ± 76 5693 [84] 
E.coli 
 
β-Casein Trx 1.13 ± 0.11 45 ± 13 1500 [84] 







8E-4  ± 3E-5 
0.06 ± 0.002 
36 ± 17  1.4 [164] 
105.7 ± 10.4 35 Results 
Human 
 
KIFM(O)K(a) DTT 0.36 ± 0.04 100.5 ± 19.8 211 Results 
Human 
 
dabsyl-Met(O) Trx 0.07 ± 0.008 190 ± 20 23 [164] 
E.coli 
 
MRP4 Trx 1.04 ± 0.16 70 ± 20 894 [84] 
E.coli 
 
β-Casein Trx 0.78 ± 0.05 54 ± 9 864 [84] 
 (a)The peptide is N-acetylated, with C-terminal Dnp-labeled. 
 
5.2.4 Activity determination for fungal MsrA and the mutants  
The data of the present study suggest that peptide substrates with positively charged residues 
adjacent to Met(O) are preferentially reduced by fungal MsrA as well as the mutants, which supports 
the findings in the previous study [42]. This is also in accordance with the literature which also 
reported that peptide substrates with amino acids such as Asp or Pro adjacent to Met(O) cannot be 
efficiently reduced by MsrA enzyme [72].  
Wild-type MsrA (Glu99, Asp134) displayed the highest activity for all substrate compared to the 
mutants. Substitution of Glu99 by Gln (mutant EQ) resulted in the lowest activity towards all 
substrate except for KNM(O)DK, while replacement of Asp134 by Asn134 (mutant DN) lead to a 
higher activity towards KDM(O)NK than KNM(O)DK. It might be speculated that asymmetric 
negative charges in the enzyme active center correspond to the reversed substrate preference. The 
mutant DE (Glu99, Glu134) showed higher activity towards all the substrates than other mutants but 
was not found more active than wild-type fungal MsrA in the reduction of peptide substrate with 
negatively charged amino acids flanking Met(O) as described in the previous study [42]. 
5.2 Assays for Msr enzymes 
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In an attempt to rationalize the activity towards the peptide substrates, molecular modelling studies 
were conducted. The docking was successful in placing the Met-S-(O) residue in its predicted 
position. However, there was no pronounced binding pockets for the tested peptides, which may be 
explained by that the peptide substrate was too short to dock into the right place in the enzyme. 
Nonetheless, the model showed that Glu99 in the active site pocket was buried in the Met-S-(O) 
binding site and probably served as a conserved residue that contributed to the right placing of Met-
S-(O). Consequently, the wild-type fungal MsrA showed the higher activity than the EQ mutant, in 
which Glu99 was substituted with a Gln residue. While Glu134 showed only H-bond interactions 
with the backbone of Met-S-(O) peptide. There were no indications that it might also interact with 











































Within this thesis stereospecific CE assays including off-line and in-capillary assays have been 
established for the study of stereospecificity of Msr enzymes. The substrates composed free Met(O), 
Met(O) derivative as well as Met(O)-containing peptides. Upon establishment of the separation 
conditions, the methods were validated and successfully applied for analyzing recombinant human 
and fungal MsrA and MsrB enzymes. Since the successful separation of Met(O) diastereomers, the 
stereospecificity of Msr enzymes was clearly demonstrated. Besides, the established methods could 
also be used for the determination of the Michaelis-Menten kinetic data.  
An off-line assay was developed using free Met(O) as substrate. The advantage of the assay over 
existing assays is the fact that free Met(O) can be used as the natural substrate. In the assay, DTT was 
used as reducing agent for Msr recycling instead of using the coupled reaction involving Trx and Trx 
reductase so that no additional enzymes were required. An in-capillary EMMA assay was established 
using Fmoc-Met(O) as substrate. Compared to the off-line assay, the EMMA assay was fully 
automated and required smaller amounts of enzyme and substrates, thus, reducing the overall cost of 
the assays. The first stereospecific assay employed a peptide substrate [KIFM(O)K] which appeared 
to be a better substrate than Met(O) derivatives such as dabsyl-Met(O) and Fmoc-Met(O). Thus, it 
may represent enzyme activities towards protein-bound Met(O) in a better way compared to simple 
amino acid derivative-based assay. A group of synthetic Met(O)-containing peptide was applied in 
order to investigate the preference of recombinant MsrA enzymes including enzyme mutants towards 
peptide substrates. Molecular modelling was attempted to rationalize the importance of amino acid in 
the active site of MsrA for the binding of the substrate. In the final part, the separation of Met(O)-
containing peptide diastereomers was studied in a systematic way with regard to buffer additives 
such as cyclodextrins and crown ethers. While basic Met(O)-containing peptides were resolved by 
the dual system composed of cyclodextrins and crown ethers, the separation of the diastereomers of 
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